Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives

Pharmacological Research

Volumn 112, Issue , 2016, Pages 4-29

  Dutra, Rafael C ^a   Campos, Maria M ^b   Santos, Adair R S ^a   Calixto, João B ^c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Centro de Inova ão e Ensaios Pré Clínicos CIEnP   (Brazil)

Author keywords

Biodiversity; Cordia verbenacea; Euphorbia tirucalli; Euterpe oleracea; Herbal drugs development; Hypericum; Mandevilla velutina; Maytenus ilicifolia; Medicinal plants; Phytomedicine; Protium; Trichilia catigua; Vitis labrusca

Indexed keywords

ABRILAR; CORDIA VERBENACEA EXTRACT; EMBLICA OFFICINALIS EXTRACT; EPAREMA; EUPHORBIA HYSSOPIFOLIA EXTRACT; EUPHORBIA MILII EXTRACT; EUPHORBIA PEPLUS EXTRACT; EUPHORBIA SPLENDENS EXTRACT; EUPHORBIA TIRUCALLI EXTRACT; EUTERPE OLERACEA EXTRACT; FORFIG; GINKOLAB; HYPERICUM CAPRIFOLIATUM EXTRACT; HYPERICUM POLYANTHEMUM EXTRACT; MANDEVILLA VELUTINA EXTRACT; MAYTENUS ILICIFOLIA EXTRACT; PASALIX; PHYLLANTHUS AMARUS EXTRACT; PHYLLANTHUS FLEXUOSUS EXTRACT; PHYLLANTHUS NIRURI EXTRACT; PHYLLANTHUS SELLOWIANUS EXTRACT; PHYLLANTHUS URINARIA EXTRACT; PLANT EXTRACT; PROTIUM HEPTAPHYLIUM EXTRACT; PROTIUM KLEINII EXTRACT; SEAKALM; TAMARINE; TRICHILIA CATIGUA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITIS LABRUSCA EXTRACT;

BARK; BIODIVERSITY; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDUSTRY; DRUG SYNTHESIS; FLOWER; FRUIT; GASTROINTESTINAL DISEASE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MEDICINAL PLANT; NONHUMAN; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLANT LEAF; PLANT ROOT; PLANT STEM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASES; DRUG DEVELOPMENT; ECONOMICS; GASTROINTESTINAL DISEASES; ISOLATION AND PURIFICATION; METABOLIC DISEASES; PHYTOTHERAPY; RESPIRATION DISORDERS;

ANIMALS; BIODIVERSITY; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASES; DRUG DISCOVERY; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION; METABOLIC DISEASES; PAIN; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RESPIRATION DISORDERS;

EID: 84956633785     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.01.021     Document Type: Review

References (379)

1. [1] Calixto, J.B., Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 33 (2000), 179–189.
2. [2] Newman, D.J., Cragg, G.M., Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75 (2012), 311–335.
3. [3] Cragg, G.M., Newman, D.J., Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830 (2013), 3670–3695.
4. [4] Mishra, B.B., Tiwari, V.K., Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem. 46 (2011), 4769–4807.
5. [5] Valli, M., dos Santos, R.N., Figueira, L.D., Nakajima, C.H., Castro-Gamboa, I., Andricopulo, A.D., Bolzani, V.S., Development of a natural products database from the biodiversity of Brazil. J. Nat. Prod. 76 (2013), 439–444.
6. [6] Harvey, A.L., Edrada-Ebel, R., Quinn, R.J., The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14 (2015), 111–129.
7. [7] Sheridan, C., Recasting natural product research. Nat. Biotechnol. 30 (2012), 385–387.
8. [8] Dale, R.C., Brilot, F., Biomarkers of inflammatory and auto-immune central nervous system disorders. Curr. Opin. Pediatr. 22 (2010), 718–725.
9. [9] Sherin, J.E., Nemeroff, C.B., Post-traumatic stress disorder: the neurobiological impact of psychological trauma. Dialogues Clin. Neurosci. 13 (2011), 263–278.
10. [10] Pardridge, W.M., Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metab. 32 (2012), 1959–1972.
11. [11] Barbosa, N.R., Pittella, F., Gattaz, W.F., Centella asiatica water extract inhibits ipla2 and cpla2 activities in rat cerebellum. Phytomedicine 15 (2008), 896–900.
12. [12] de Lima, K.C., Schilichting, C.L., Junior, L.A., da Silva, F.M., Benetoli, A., Milani, H., The ginkgo biloba extract, EGb 761, fails to reduce brain infarct size in rats after transient, middle cerebral artery occlusion in conditions of unprevented, ischemia-induced fever. Phytother. Res. 20 (2006), 438–443.
13. [13] Chavez, J.H., Leal, P.C., Yunes, R.A., Nunes, R.J., Barardi, C.R., Pinto, A.R., Simoes, C.M., Zanetti, C.R., Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus. Vet. Microbiol. 116 (2006), 53–59.
14. [14] Barreiros, V.C., Dias, F.J., Iyomasa, M.M., Coutinho-Netto, J., de Sousa, L.G., Fazan, V.P., Antunes Rde, S., Watanabe, I.S., Issa, J.P., Morphological and morphometric analyses of crushed sciatic nerves after application of a purified protein from natural latex and hyaluronic acid hydrogel. Growth Factors 32 (2014), 164–170.
15. [15] Nishijima, C.M., Ganev, E.G., Mazzardo-Martins, L., Martins, D.F., Rocha, L.R., Santos, A.R., Hiruma-Lima, C.A., Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain. Eur. J. Pharmacol. 736 (2014), 16–25.
16. [16] Perez, M., Benitez, S.U., Cartarozzi, L.P., Del Bel, E., Guimaraes, F.S., Oliveira, A.L., Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. Eur. J. Neurosci. 38 (2013), 3424–3434.
17. [17] Klein-Junior, L.C., Meira, N.A., Bresolin, T.M., Cechinel-Filho, V., Quintao, N.L., Antihyperalgesic activity of the methanol extract and some constituents obtained from polygala cyparissias (polygalaceae). Basic Clin. Pharmacol. Toxicol. 111 (2012), 145–153.
18. [18] da Silva, K.A., Manjavachi, M.N., Paszcuk, A.F., Pivatto, M., Viegas, C. Jr., Bolzani, V.S., Calixto, J.B., Plant derived alkaloid (−)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models. Neuropharmacology 62 (2012), 967–977.
19. [19] Kassuya, C.A., Silvestre, A.A., Rehder, V.L., Calixto, J.B., Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. Eur. J. Pharmacol. 478 (2003), 145–153.
20. [20] Aragao, G.F., Carneiro, L.M., Rota-Junior, A.P., Bandeira, P.N., de Lemos, T.L., Viana, G.S., Alterations in brain amino acid metabolism and inhibitory effects on pkc are possibly correlated with anticonvulsant effects of the isomeric mixture of alpha- and beta-amyrin from Protium heptaphyllum. Pharm. Biol. 53 (2015), 407–413.
21. [21] Marques, T.H., Marques, M.L., Medeiros, J.V., Lima, T.C., de Sousa, D.P., de Freitas, R.M., Anticonvulsant effects of acute treatment with cyane-carvone at repeated oral doses in epilepsy models. Pharmacology, biochemistry, and behavior 124 (2014), 421–424.
22. [22] Nobrega, F.F., Salvadori, M.G., Masson, C.J., Mello, C.F., Nascimento, T.S., Leal-Cardoso, J.H., de Sousa, D.P., Almeida, R.N., Monoterpenoid terpinen-4-ol exhibits anticonvulsant activity in behavioural and electrophysiological studies. Oxid. Med. Cell. Longev., 2014, 2014, 703848.
23. [23] Branco Cdos, S., Scola, G., Rodrigues, A.D., Cesio, V., Laprovitera, M., Heinzen, H., Dos Santos, M.T., Fank, B., de Freitas, S.C., Coitinho, A.S., Salvador, M., Anticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis st) Hil. on pentylenetetrazol-induced seizures in wistar rats. Brain Res. Bull. 92 (2013), 60–68.
24. [24] Faggion, S.A., Cunha, A.O., Fachim, H.A., Gavin, A.S., dos Santos, W.F., Pereira, A.M., Beleboni, R.O., Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-alpha-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex. Benth (leguminosae-papilionaceae). Epilepsy Behav. 20 (2011), 441–446.
25. [25] Duarte, F.S., Duzzioni, M., Mendes, B.G., Pizzolatti, M.G., De Lima, T.C., Participation of dihydrostyryl-2-pyrones and styryl-2-pyrones in the central effects of polygala sabulosa (polygalaceae), a folk medicine topical anesthetic. Pharmacol. Biochem. Behav. 86 (2007), 150–161.
26. [26] Viana, G.S., do Vale, T.G., Silva, C.M., Matos, F.J., Anticonvulsant activity of essential oils and active principles from chemotypes of Lippia alba (Mill.) n. E. Brown. Biol. Pharm. Bull. 23 (2000), 1314–1317.
27. [27] Antunes, M.S., Goes, A.T., Boeira, S.P., Prigol, M., Jesse, C.R., Protective effect of hesperidin in a model of parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition 30 (2014), 1415–1422.
28. [28] Campos, H.C., da Rocha, M.D., Viegas, F.P., Nicastro, P.C., Fossaluzza, P.C., Fraga, C.A., Barreiro, E.J., Viegas, C. Jr., The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders i: Parkinson's disease. CNS Neurol. Disord. Drug Targets 10 (2011), 239–250.
29. [29] Moreira, E.L., Rial, D., Aguiar, A.S. Jr., Figueiredo, C.P., Siqueira, J.M., DalBo, S., Horst, H., de Oliveira, J., Mancini, G., dos Santos, T.S., Villarinho, J.G., Pinheiro, F.V., Marino-Neto, J., Ferreira, J., De Bem, A.F., Latini, A., Pizzolatti, M.G., Ribeiro-do-Valle, R.M., Prediger, R.D., Proanthocyanidin-rich fraction from croton celtidifolius baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of parkinson's disease. J. Neural Trans. 117 (2010), 1337–1351.
30. [30] Milioli, E.M., Cologni, P., Santos, C.C., Marcos, T.D., Yunes, V.M., Fernandes, M.S., Schoenfelder, T., Costa-Campos, L., Effect of acute administration of hydroalcohol extract of ilex paraguariensis st hilaire (aquifoliaceae) in animal models of parkinson's disease. Phytother. Res. 21 (2007), 771–776.
31. [31] Bittencourt Lda, S., Zeidan-Chulia, F., Yatsu, F.K., Schnorr, C.E., Moresco, K.S., Kolling, E.A., Gelain, D.P., Bassani, V.L., Moreira, J.C., Guarana (Paullinia cupana Mart.) prevents beta-amyloid aggregation, generation of advanced glycation-end products (ages), and acrolein-induced cytotoxicity on human neuronal-like cells. Phytother. Res. 28 (2014), 1615–1624.
32. [32] da Rocha, M.D., Viegas, F.P., Campos, H.C., Nicastro, P.C., Fossaluzza, P.C., Fraga, C.A., Barreiro, E.J., Viegas, C. Jr., The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders ii: Alzheimer's disease. CNS Neurol. Disord. Drug Targets 10 (2011), 251–270.
33. [33] Figueiro, M., Ilha, J., Linck, V.M., Herrmann, A.P., Nardin, P., Menezes, C.B., Achaval, M., Goncalves, C.A., Porciuncula, L.O., Nunes, D.S., Elisabetsky, E., The amazonian herbal marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse alzheimer model. Phytomedicine 18 (2011), 327–333.
34. [34] Dias, D.S., Fontes, L.B., Crotti, A.E., Aarestrup, B.J., Aarestrup, F.M., da Silva Filho, A.A., Correa, J.O., Copaiba oil suppresses inflammatory cytokines in splenocytes of c57bl/6 mice induced with experimental autoimmune encephalomyelitis (eae). Molecules 19 (2014), 12814–12826.
35. [35] Alberti, T.B., Marcon, R., Bicca, M.A., Raposo, N.R., Calixto, J.B., Dutra, R.C., Essential oil from pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating th1/treg cell balance. J. Ethnopharmacol. 155 (2014), 485–494.
36. [36] Gureje, O., Von Korff, M., Simon, G.E., Gater, R., Persistent pain and well-being: a world health organization study in primary care. Jama 280 (1998), 147–151.
37. [37] Bond, M., Pain education issues in developing countries and responses to them by the international association for the study of pain. Pain Res. Manag. 16 (2011), 404–406.
38. [38] Goldberg, D.S., McGee, S.J., Pain as a global public health priority. BMC Public Health, 11, 2011, 770.
39. [39] Reardon, D.P., Anger, K.E., Szumita, P.M., Pathophysiology, assessment, and management of pain in critically ill adults. Am. J. Health System Pharm. 72 (2015), 1531–1543.
40. [40] Grichnik, K.P., Ferrante, F.M., The difference between acute and chronic pain. Mt. Sinai J. Med. N. Y. 58 (1991), 217–220.
41. [41] Mendes, G.L., Santos, A.R., Campos, M.M., Tratsk, K.S., Yunes, R.A., Cechinel Filho, V., Calixto, J.B., Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (winteraceae). Life Sci. 63 (1998), 369–381.
42. [42] Malheiros, A., Filho, V.C., Schmitt, C.B., Santos, A.R.S., Scheidt, C., Calixto, J.B., Monache, F.D., Yunes, R.A., A sesquiterpene drimane with antinociceptive activity from drimys winteri bark. Phytochemistry 57 (2001), 103–107.
43. [43] Mendes, G.L., Santos, A.R., Malheiros, A., Filho, V.C., Yunes, R.A., Calixto, J.B., Assessment of mechanisms involved in antinociception caused by sesquiterpene polygodial. J. Pharmacol. Exp. Ther. 292 (2000), 164–172.
44. [44] Scheidt, C., Santos, A.R., Ferreira, J., Malheiros, A., Cechinel-Filho, V., Yunes, R.A., Calixto, J.B., Evidence for the involvement of glutamatergic receptors in the antinociception caused in mice by the sesquiterpene drimanial. Neuropharmacology 43 (2002), 340–347.
45. [45] Andre, E., Campi, B., Trevisani, M., Ferreira, J., Malheiros, A., Yunes, R.A., Calixto, J.B., Geppetti, P., Pharmacological characterisation of the plant sesquiterpenes polygodial and drimanial as vanilloid receptor agonists. Biochem. Pharmacol. 71 (2006), 1248–1254.
46. [46] Martini, L.H., Cereser, L., Junior, I.Z., Jardim, F.M., Vendite, D.A., Frizzo, M.E., Yunes, R.A., Calixto, J.B., Wofchuk, S., Souza, D.O., The sesquiterpenes polygodial and drimanial in vitro affect glutamatergic transport in rat brain. Neurochem. Res. 31 (2006), 431–438.
47. [47] Andre, E., Ferreira, J., Malheiros, A., Yunes, R.A., Calixto, J.B., Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats. Neuropharmacology 46 (2004), 590–597.
48. [48] dos Santos Filho, D., Gilbert, B., Prophylaxis of schistosomiasis by the fruit oil of Pterodon pubescens Benth. Boletim Faculdade Farmacia Odontologia Ribeirao Preto 6 (1969), 142–149.
49. [49] Mahajan, J.R., Monteiro, M.B., New diterpenoids from Pterodon emarginatus vog. J. Chem. Soc. Perkin Trans. 1 5 (1973), 520–525.
50. [50] Duarte, I.D., Ferreira-Alves, D.L., Nakamura-Craig, M., Possible participation of endogenous opioid peptides on the mechanism involved in analgesia induced by vouacapan. Life Sci. 50 (1992), 891–897.
51. [51] Duarte, I.D., Ferreira-Alves, D.L., Veloso, D.P., Nakamura-Craig, M., Evidence of the involvement of biogenic amines in the antinociceptive effect of a vouacapan extracted from Pterodon polygalaeflorus Benth. J. Ethnopharmacol. 55 (1996), 13–18.
52. [52] Coelho, L.P., Reis, P.A., de Castro, F.L., Gayer, C.R., da Silva Lopes, C., da Costa e Silva, M.C., de Carvalho Sabino, K.C., Todeschini, A.R., Coelho, M.G., Antinociceptive properties of ethanolic extract and fractions of Pterodon pubescens Benth. seeds. J. Ethnopharmacol. 98 (2005), 109–116.
53. [53] Spindola, H.M., Servat, L., Denny, C., Rodrigues, R.A., Eberlin, M.N., Cabral, E., Sousa, I.M., Tamashiro, J.Y., Carvalho, J.E., Foglio, M.A., Antinociceptive effect of geranylgeraniol and 6alpha,7beta-dihydroxyvouacapan-17beta-oate methyl ester isolated from Pterodon pubescens Benth. BMC Pharmacol., 10, 2010, 1.
54. [54] Spindola, H.M., Servat, L., Rodrigues, R.A., Sousa, I.M., Carvalho, J.E., Foglio, M.A., Geranylgeraniol and 6alpha,7beta-dihydroxyvouacapan-17beta-oate methyl ester isolated from Pterodon pubescens Benth.: further investigation on the antinociceptive mechanisms of action. Eur. J. Pharmacol. 656 (2011), 45–51.
55. [55] de Moraes, W.F., Galdino, P.M., Nascimento, M.V., Vanderlinde, F.A., Bara, M.T., Costa, E.A., de Paula, J.R., Triterpenes involved in the anti-inflammatory effect of ethanolic extract of Pterodon emarginatus vogel stem bark. J. Nat. Med. 66 (2012), 202–207.
56. [56] Nucci, C., Mazzardo-Martins, L., Stramosk, J., Brethanha, L.C., Pizzolatti, M.G., Santos, A.R., Martins, D.F., Oleaginous extract from the fruits Pterodon pubescens Benth induces antinociception in animal models of acute and chronic pain. J. Ethnopharmacol. 143 (2012), 170–178.
57. [57] Negri, G., Mattei, R., Mendes, F.R., Antinociceptive activity of the HPLC- and MS-standardized hydroethanolic extract of Pterodon emarginatus vogel leaves. Phytomedicine 21 (2014), 1062–1069.
58. [58] Sabino, K.C., Gayer, C.R., Vaz, L.C., Santos, L.R., Felzenszwalb, I., Coelho, M.G., In vitro and in vivo toxicological study of the Pterodon pubescens seed oil. Toxicol. Lett. 108 (1999), 27–35.
59. [59] Dutra, R.C., Fava, M.B., Alves, C.C., Ferreira, A.P., Barbosa, N.R., Antiulcerogenic and anti-inflammatory activities of the essential oil from pterodon emarginatus seeds. J. Pharm. Pharmacol. 61 (2009), 243–250.
60. [60] Sabino, K.C., Castro, F.A., Oliveira, J.C., Dalmau, S.R., Coelho, M.G., Successful treatment of collagen-induced arthritis in mice with a hydroalcohol extract of seeds of Pterodon pubescens. Phytother. Res. 13 (1999), 613–615.
61. [61] Coelho, M.G., Sabino, K.C., Dalmau, S.R., Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis. Clin. Exp. Rheumatol. 22 (2004), 213–218.
62. [62] Nucci-Martins, C., Martins, D.F., Nascimento, L.F., Venzke, D., Oliveira, A.S., Frederico, M.J., Silva, F.R., Brighente, I.M., Pizzolatti, M.G., Santos, A.R., Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: evidence for the mechanisms of action. J. Ethnopharmacol., 2015.
63. [63] Calixto, N.O., da Costa e Silva, M.C., Gayer, C.R., Coelho, M.G., Paes, M.C., Todeschini, A.R., Antiplatelet activity of geranylgeraniol isolated from pterodon pubescens fruit oil is mediated by inhibition of cyclooxygenase-1. Planta Med. 73 (2007), 480–483.
64. [64] de Campos, R.O., Santos, A.R., Vaz, Z.R., Pinheiro, T.R., Pizzolatti, M.G., Cechinel Filho, V., Delle Monache, F., Yunes, R.A., Calixto, J.B., Antinociceptive properties of the hydroalcoholic extract and preliminary study of a xanthone isolated from Polygala cyparissias (polygalaceae). Life Sci. 61 (1997), 1619–1630.
65. [65] Meotti, F.C., Ardenghi, J.V., Pretto, J.B., Souza, M.M., d' Avila Moura, J., Junior, A.C., Soldi, C., Pizzolatti, M.G., Santos, A.R., Antinociceptive properties of coumarins, steroid and dihydrostyryl-2-pyrones from Polygala sabulosa (polygalaceae) in mice. J. Pharm. Pharmacol. 58 (2006), 107–112.
66. [66] Ribas, C.M., Meotti, F.C., Nascimento, F.P., Jacques, A.V., Dafre, A.L., Rodrigues, A.L., Farina, M., Soldi, C., Mendes, B.G., Pizzolatti, M.G., Santos, A.R., Antinociceptive effect of the polygala sabulosa hydroalcoholic extract in mice: evidence for the involvement of glutamatergic receptors and cytokine pathways. Basic Clin. Pharmacol. Toxicol. 103 (2008), 43–47.
67. [67] Lapa Fda, R., Gadotti, V.M., Missau, F.C., Pizzolatti, M.G., Marques, M.C., Dafre, A.L., Farina, M., Rodrigues, A.L., Santos, A.R., Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata l. in mice. Basic Clin. Pharmacol. Toxicol. 104 (2009), 306–315.
68. [68] Trentin, A.P., Santos, A.R., Miguel, O.G., Pizzolatti, M.G., Yunes, R.A., Calixto, J.B., Mechanisms involved in the antinociceptive effect in mice of the hydroalcoholic extract of Siphocampylus verticillatus. J. Pharm. Pharmacol. 49 (1997), 567–572.
69. [69] Santos, A.R., Miguel, O.G., Yunes, R.A., Calixto, J.B., Antinociceptive properties of the new alkaloid, cis-8,10-di-n-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: evidence for the mechanism of action. J. Pharmacol. Exp. Ther. 289 (1999), 417–426.
70. [70] Yang, G., Gao, J., Jia, Y., Yan, L., Yu, J., Jiang, Y., Oxysophoridine through intrathecal injection induces antinociception and increases the expression of the gabaaalpha1 receptor in the spinal cord of mice. Planta Med. 78 (2012), 874–880.
71. [71] Xu, T., Li, Y., Wang, H., Xu, Y., Ma, L., Sun, T., Ma, H., Yu, J., Oxysophocarpine induces anti-nociception and increases the expression of gabaaalpha1 receptors in mice. Mol. Med. Rep. 7 (2013), 1819–1825.
72. [72] Rodrigues, A.L., da Silva, G.L., Mateussi, A.S., Fernandes, E.S., Miguel, O.G., Yunes, R.A., Calixto, J.B., Santos, A.R., Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci. 70 (2002), 1347–1358.
73. [73] Williams, J.P., Meyers, J.A., Immune-mediated inflammatory disorders (i.M.I.D.S): the economic and clinical costs. Am. J. Manag. Care 8 (2002), S664–S681 quiz S682-665.
74. [74] Janeway, C.A., Immunobiology 5: The Immune System in Health and Disease. 5th ed., 2001, Churchill Livingstone, New York: Garland; Edinburgh.
75. [75] Yach, D., Hawkes, C., Gould, C.L., Hofman, K.J., The global burden of chronic diseases: overcoming impediments to prevention and control. Jama 291 (2004), 2616–2622.
76. [76] Botelho, M.A., dos Santos, R.A., Martins, J.G., Carvalho, C.O., Paz, M.C., Azenha, C., Ruela, R.S., Queiroz, D.B., Ruela, W.S., Marinho, G., Ruela, F.I., Comparative effect of an essential oil mouthrinse on plaque, gingivitis and salivary streptococcus mutans levels: a double blind randomized study. Phytother. Res. 23 (2009), 1214–1219.
77. [77] Colpo, E., Dalton, D.A.V.C., Reetz, L.G., Duarte, M.M., Farias, I.L., Meinerz, D.F., Mariano, D.O., Vendrusculo, R.G., Boligon, A.A., Dalla Corte, C.L., Wagner, R., Athayde, M.L., da Rocha, J.B., Brazilian nut consumption by healthy volunteers improves inflammatory parameters. Nutrition 30 (2014), 459–465.
78. [78] Stockler-Pinto, M.B., Mafra, D., Moraes, C., Lobo, J., Boaventura, G.T., Farage, N.E., Silva, W.S., Cozzolino, S.F., Malm, O., Brazil nut (Bertholletia excelsa, h.B.K.) improves oxidative stress and inflammation biomarkers in hemodialysis patients. Biol. Trace Elem. Res. 158 (2014), 105–112.
79. [79] Stockler-Pinto, M.B., Malm, O., Moraes, C., Farage, N.E., Silva, W.S., Cozzolino, S.M., Mafra, D., A follow-up study of the chronic kidney disease patients treated with Brazil nut: focus on inflammation and oxidative stress. Biol. Trace Elem. Res. 163 (2015), 67–72.
80. [80] Viecili, P.R., Borges, D.O., Kirsten, K., Malheiros, J., Viecili, E., Melo, R.D., Trevisan, G., da Silva, M.A., Bochi, G.V., Moresco, R.N., Klafke, J.Z., Effects of Campomanesia xanthocarpa on inflammatory processes, oxidative stress, endothelial dysfunction and lipid biomarkers in hypercholesterolemic individuals. Atherosclerosis 234 (2014), 85–92.
81. [81] Toscano, L.T., da Silva, C.S., Toscano, L.T., de Almeida, A.E., Santos Ada, C., Silva, A.S., Chia flour supplementation reduces blood pressure in hypertensive subjects. Plant Foods Hum. Nutr. 69 (2014), 392–398.
82. [82] Luna, L.A. Jr., Bachi, A.L., Novaes e Brito, R.R., Eid, R.G., Suguri, V.M., Oliveira, P.W., Gregorio, L.C., Vaisberg, M., Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15. Phytomedicine 18 (2011), 303–308.
83. [83] Bopp, A., De Bona, K.S., Belle, L.P., Moresco, R.N., Moretto, M.B., Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fundam. Clin. Pharmacol. 23 (2009), 501–507.
84. [84] Brusselle, G.G., Provoost, S., Bracke, K.R., Kuchmiy, A., Lamkanfi, M., Inflammasomes in respiratory disease: from bench to bedside. Chest 145 (2014), 1121–1133.
85. [85] Holtzman, M.J., Byers, D.E., Alexander-Brett, J., Wang, X., The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat. Rev. Immunol. 14 (2014), 686–698.
86. [86] Njoroge, G.N., Bussmann, R.W., Traditional management of ear, nose and throat (ent) diseases in central kenya. J. Ethnobiol. Ethnomed., 2, 2006, 54.
87. [87] Ballabh, B., Chaurasia, O.P., Traditional medicinal plants of cold desert ladakh—used in treatment of cold, cough and fever. J. Ethnopharmacol. 112 (2007), 341–349.
88. [88] Kim, H., Song, M.J., Traditional plant-based therapies for respiratory diseases found in north jeolla province, korea. J. Altern. Complement. Med. 18 (2012), 287–293.
89. [89] Rigat, M., Valles, J., Iglesias, J., Garnatje, T., Traditional and alternative natural therapeutic products used in the treatment of respiratory tract infectious diseases in the eastern catalan pyrenees (iberian peninsula). J. Ethnopharmacol. 148 (2013), 411–422.
90. [90] Cavero, R.Y., Calvo, M.I., Medicinal plants used for respiratory affections in navarra and their pharmacological validation. J. Ethnopharmacol. 158:Pt A (2014), 216–220.
91. [91] Kayani, S., Ahmad, M., Zafar, M., Sultana, S., Khan, M.P., Ashraf, M.A., Hussain, J., Yaseen, G., Ethnobotanical uses of medicinal plants for respiratory disorders among the inhabitants of gallies—Abbottabad, northern Pakistan. J. Ethnopharmacol. 156 (2014), 47–60.
92. [92] Napimoga, M.H., Yatsuda, R., Scientific evidence for mikania laevigata and mikania glomerata as a pharmacological tool. J. Pharm. Pharmacol. 62 (2010), 809–820.
93. [93] dos Santos, S.C., Krueger, C.L., Steil, A.A., Kreuger, M.R., Biavatti, M.W., Wisniewski Junior, A., Lc characterisation of guaco medicinal extracts, mikania laevigata and m Glomerata, and their effects on allergic pneumonitis. Planta Med. 72 (2006), 679–684.
94. [94] Fierro, I.M., da Silva, A.C., Lopes Cda, S., de Moura, R.S., Barja-Fidalgo, C., Studies on the anti-allergic activity of mikania glomerata. J. Ethnopharmacol. 66 (1999), 19–24.
95. [95] Thavorn, K., Mamdani, M.M., Straus, S.E., Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol. Syst. Rev., 3, 2014, 71.
96. [96] Tillisch, K., Complementary and alternative medicine for functional gastrointestinal disorders. Gut 55 (2006), 593–596.
97. [97] Souza-Formigoni, M.L., Oliveira, M.G., Monteiro, M.G., da Silveira-Filho, N.G., Braz, S., Carlini, E.A., Antiulcerogenic effects of two maytenus species in laboratory animals. J. Ethnopharmacol. 34 (1991), 21–27.
98. [98] Vilegas, W., Sanommiya, M., Rastrelli, L., Pizza, C., 2015 Isolation and structure elucidation of two new flavonoid glycosides from the infusion of Maytenus aquifolium leaves. Evaluation of the antiulcer activity of the infusion. J. Agric. Food Chem. 47 (1999), 403–406.
99. [99] Antonio, M.A., Souza Brito, A.R., Oral anti-inflammatory and anti-ulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (turneraceae). J. Ethnopharmacol. 61 (1998), 215–228.
100. [100] Gracioso Jde, S., Vilegas, W., Hiruma-Lima, C.A., Souza Brito, A.R., Effects of tea from Turnera ulmifolia l. On mouse gastric mucosa support the turneraceae as a new source of antiulcerogenic drugs. Biol. Pharm. Bull. 25 (2002), 487–491.
101. [101] Paiva, L.A., Rao, V.S., Gramosa, N.V., Silveira, E.R., Gastroprotective effect of Copaifera langsdorffii oleo-resin on experimental gastric ulcer models in rats. J. Ethnopharmacol. 62 (1998), 73–78.
102. [102] Martins, J.L., Rodrigues, O.R., da Silva, D.M., Galdino, P.M., de Paula, J.R., Romao, W., da Costa, H.B., Vaz, B.G., Ghedini, P.C., Costa, E.A., Mechanisms involved in the gastroprotective activity of Celtis iguanaea (Jacq.) sargent on gastric lesions in mice. J. Ethnopharmacol. 155 (2014), 1616–1624.
103. [103] Junior, F.E., de Oliveira, D.R., Boligon, A.A., Athayde, M.L., Kamdem, J.P., Macedo, G.E., da Silva, G.F., de Menezes, I.R., Costa, J.G., Coutinho, H.D., Kerntopf, M.R., Posser, T., Protective effects of Croton campestris A. St-Hill in different ulcer models in rodents: evidence for the involvement of nitric oxide and prostaglandins. J. Ethnopharmacol. 153 (2014), 469–477.
104. [104] Moraes, T.M., Rozza, A.L., Kushima, H., Pellizzon, C.H., Rocha, L.R., Hiruma-Lima, C.A., Healing actions of essential oils from Citrus aurantium and D-limonene in the gastric mucosa: the roles of VEGF, PCNA, AND COX-2 in cell proliferation. J. Med. Food 16 (2013), 1162–1167.
105. [105] Caldas, G.F., Oliveira, A.R., Araujo, A.V., Quixabeira, D.C., Silva-Neto Jda, C., Costa-Silva, J.H., de Menezes, I.R., Ferreira, F., Leite, A.C., da Costa, J.G., Wanderley, A.G., Gastroprotective and ulcer healing effects of essential oil of Hyptis martiusii Benth. (lamiaceae). PLoS One, 9, 2014, e84400.
106. [106] Pereira, I.T., Burci, L.M., da Silva, L.M., Baggio, C.H., Heller, M., Micke, G.A., Pizzolatti, M.G., Marques, M.C., Werner, M.F., Antiulcer effect of bark extract of Tabebuia avellanedae: activation of cell proliferation in gastric mucosa during the healing process. Phytother. Res. 27 (2013), 1067–1073.
107. [107] Luiz-Ferreira, A., Cola, M., Barbastefano, V., de-Faria, F.M., Almeida, A.B., Farias-Silva, E., Calvo, T.R., Hiruma-Lima, C.A., Vilegas, W., Souza-Brito, A.R., Healing, antioxidant and cytoprotective properties of Indigofera truxillensis in different models of gastric ulcer in rats. Int. J. Mol. Sci. 13 (2012), 14973–14991.
108. [108] Rodrigues Orsi, P., Bonamin, F., Aparecida Severi, J., Cassia Santos, R., Vilegas, W., Hiruma-Lima, C.A., Stasi, L.C., Hymenaea stigonocarpa Mart. ex Hayne: a Brazilian medicinal plant with gastric and duodenal anti-ulcer and antidiarrheal effects in experimental rodent models. J. Ethnopharmacol. 143 (2012), 81–90.
109. [109] Santos, R.C., Kushima, H., Rodrigues, C.M., Sannomiya, M., Rocha, L.R., Bauab, T.M., Tamashiro, J., Vilegas, W., Hiruma-Lima, C.A., Byrsonima intermedia A. Juss.: gastric and duodenal anti-ulcer, antimicrobial and antidiarrheal effects in experimental rodent models. J. Ethnopharmacol. 140 (2012), 203–212.
110. [110] Luiz-Ferreira, A., Almeida, A.C., Cola, M., Barbastefano, V., Almeida, A.B., Batista, L.M., Farias-Silva, E., Pellizzon, C.H., Hiruma-Lima, C.A., Santos, L.C., Vilegas, W., Brito, A.R., Mechanisms of the gastric antiulcerogenic activity of Anacardium humile St. Hil. on ethanol-induced acute gastric mucosal injury in rats. Molecules 15 (2010), 7153–7166.
111. [111] Carlotto, J., da Silva, L.M., Dartora, N., Maria-Ferreira, D., Sabry Dde, A., Filho, A.P., de Paula Werner, M.F., Sassaki, G.L., Gorin, P.A., Iacomini, M., Cipriani, T.R., de Souza, L.M., Identification of a dicaffeoylquinic acid isomer from Arctium lappa with a potent anti-ulcer activity. Talanta 135 (2015), 50–57.
112. [112] Bonamin, F., Moraes, T.M., Dos Santos, R.C., Kushima, H., Faria, F.M., Silva, M.A., Junior, I.V., Nogueira, L., Bauab, T.M., Souza Brito, A.R., da Rocha, L.R., Hiruma-Lima, C.A., The effect of a minor constituent of essential oil from Citrus aurantium: the role of beta-myrcene in preventing peptic ulcer disease. Chem. Biol. Interact. 212 (2014), 11–19.
113. [113] Rozza, A.L., Moraes Tde, M., Kushima, H., Tanimoto, A., Marques, M.O., Bauab, T.M., Hiruma-Lima, C.A., Pellizzon, C.H., Gastroprotective mechanisms of citrus lemon (rutaceae) essential oil and its majority compounds limonene and beta-pinene: involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide and prostaglandin e(2). Chem. Biol. Interact. 189 (2011), 82–89.
114. [114] Maria-Ferreira, D., da Silva, L.M., Mendes, D.A., Cabrini Dde, A., Nascimento, A.M., Iacomini, M., Cipriani, T.R., Santos, A.R., Werner, M.F., Baggio, C.H., Rhamnogalacturonan from Acmella oleracea (l.) r.K. Jansen: gastroprotective and ulcer healing properties in rats. PLoS One, 9, 2014, e84762.
115. [115] Silva, F.V., Guimaraes, A.G., Silva, E.R., Sousa-Neto, B.P., Machado, F.D., Quintans-Junior, L.J., Arcanjo, D.D., Oliveira, F.A., Oliveira, R.C., Anti-inflammatory and anti-ulcer activities of carvacrol, a monoterpene present in the essential oil of oregano. J. Med. Food 15 (2012), 984–991.
116. [116] Rocha, N.F., Oliveira, G.V., Araujo, F.Y., Rios, E.R., Carvalho, A.M., Vasconcelos, L.F., Macedo, D.S., Soares, P.M., Sousa, D.P., Sousa, F.C., (–)-α-Bisabolol-induced gastroprotection is associated with reduction in lipid peroxidation, superoxide dismutase activity and neutrophil migration. Eur. J. Pharm. Sci. 44 (2011), 455–461.
117. [117] Beserra, A.M., Calegari, P.I., Souza Mdo, C., Dos Santos, R.A., Lima, J.C., Silva, R.M., Balogun, S.O., Martins, D.T., Gastroprotective and ulcer-healing mechanisms of ellagic acid in experimental rats. J. Agric. Food Chem. 59 (2011), 6957–6965.
118. [118] Rodrigues Pde, A., de Morais, S.M., de Souza, C.M., Silva, A.R., de Andrade, G.M., Silva, M.G., Albuquerque, R.L., Rao, V.S., Santos, F.A., Gastroprotective effect of barbatusin and 3-beta-hydroxy-3-deoxibarbatusin, quinonoid diterpenes isolated from Plectranthus grandis, in ethanol-induced gastric lesions in mice. J. Ethnopharmacol. 127 (2010), 725–730.
119. [119] Guedes, M.M., Carvalho, A.C., Lima, A.F., Lira, S.R., de Queiroz, S.S., Silveira, E.R., Santos, F.A., Rao, V.S., Gastroprotective mechanisms of centipedic acid, a natural diterpene from Egletes viscosa less. Biol. Pharm. Bull. 31 (2008), 1351–1355.
120. [120] Carvalho, A.C., Guedes, M.M., de Souza, A.L., Trevisan, M.T., Lima, A.F., Santos, F.A., Rao, V.S., Gastroprotective effect of mangiferin, a xanthonoid from Mangifera indica, against gastric injury induced by ethanol and indomethacin in rodents. Planta Med. 73 (2007), 1372–1376.
121. [121] Klopell, F.C., Lemos, M., Sousa, J.P., Comunello, E., Maistro, E.L., Bastos, J.K., de Andrade, S.F., Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia dc (asteraceae) Zeitschrift fur Naturforschung C. J. Biosci. 62 (2007), 537–542.
122. [122] Hiruma-Lima, C.A., Toma, W., Gracioso Jde, S., de Almeida, A.B., Batista, L.M., Magri, L., de Paula, A.C., Soares, F.R., Nunes, D.S., Souza Brito, A.R., Natural trans-crotonin: the antiulcerogenic effect of another diterpene isolated from the bark of Croton cajucara Benth. Biol. Pharm. Bull. 25 (2002), 452–456.
123. [123] Rodrigues, L.V., Ferreira, F.V., Regadas, F.S., Matos, D., Viana, G.S., Morphologic and morphometric analyses of acetic acid-induced colitis in rats after treatment with enemas from Myracrodruon urundeuva Fr. All. (aroeira do sertao). Phytother. Res. 16 (2002), 267–272.
124. [124] Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989), 795–803.
125. [125] Di Stasi, L.C., Camuesco, D., Nieto, A., Vilegas, W., Zarzuelo, A., Galvez, J., Intestinal anti-inflammatory activity of paepalantine, an isocoumarin isolated from the capitula of Paepalanthus bromelioides, in the trinitrobenzenesulphonic acid model of rat colitis. Planta Med. 70 (2004), 315–320.
126. [126] Bento, A.F., Marcon, R., Dutra, R.C., Claudino, R.F., Cola, M., Leite, D.F., Calixto, J.B., Beta-caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through cb2 receptor activation and ppargamma pathway. Am. J. Pathol. 178 (2011), 1153–1166.
127. [127] Dutra, R.C., Claudino, R.F., Bento, A.F., Marcon, R., Schmidt, E.C., Bouzon, Z.L., Pianowski, L.F., Calixto, J.B., Preventive and therapeutic euphol treatment attenuates experimental colitis in mice. PLoS One, 6, 2011, e27122.
128. [128] Vitor, C.E., Figueiredo, C.P., Hara, D.B., Bento, A.F., Mazzuco, T.L., Calixto, J.B., Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br. J. Pharmacol. 157 (2009), 1034–1044.
129. [129] Cazarin, C.B., da Silva, J.K., Colomeu, T.C., Batista, A.G., Vilella, C.A., Ferreira, A.L., Junior, S.B., Fukuda, K., Augusto, F., de Meirelles, L.R., Zollner Rde, L., Junior, M.R., Passiflora edulis peel intake and ulcerative colitis: approaches for prevention and treatment. Exp. Biol. Med. 239 (2014), 542–551.
130. [130] Paiotti, A.P., Neto, R.A., Marchi, P., Silva, R.M., Pazine, V.L., Noguti, J., Pastrelo, M.M., Gollucke, A.P., Miszputen, S.J., Ribeiro, D.A., The anti-inflammatory potential of phenolic compounds in grape juice concentrate (g8000) on 2,4,6-trinitrobenzene sulphonic acid-induced colitis. Br. J. Nutr. 110 (2013), 973–980.
131. [131] Marchi, P., Paiotti, A.P., Artigiani Neto, R., Oshima, C.T., Ribeiro, D.A., Concentrated grape juice (g8000) reduces immunoexpression of inos, tnf-alpha, cox-2 and DNA damage on 2,4,6-trinitrobenzene sulfonic acid-induced-colitis. Environ. Toxicol. Pharmacol. 37 (2014), 819–827.
132. [132] Teixeira, L.B., Epifanio, V.L., Lachat, J.J., Foss, N.T., Coutinho-Netto, J., Oral treatment with hev b 13 ameliorates experimental colitis in mice. Clin. Exp. Immunol. 169 (2012), 27–32.
133. [133] Lim, S., Eckel, R.H., Pharmacological treatment and therapeutic perspectives of metabolic syndrome. Rev. Endocr. Metab. Disord. 15 (2014), 329–341.
134. [134] Welty, F.K., Alfaddagh, A., Elajami, T.K., Targeting inflammation in metabolic syndrome. Transl. Res., 2016, 2015.
135. [135] Babajafari, S., Nikaein, F., Mazloomi, S.M., Zibaeenejad, M.J., Zargaran, A., A review of the benefits of Satureja species on metabolic syndrome and their possible mechanisms of action. J. Evid. Based Complement. Altern. Med. 20 (2015), 212–223.
136. [136] Banos, G., Perez-Torres, I., El Hafidi, M., Medicinal agents in the metabolic syndrome. Cardiovasc. Hematol. Agents Med. Chem. 6 (2008), 237–252.
137. [137] Perez-Torres, I., Ruiz-Ramirez, A., Banos, G., El-Hafidi, M., Hibiscus sabdariffa linnaeus (malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovasc. Hematol. Agents Med. Chem. 11 (2013), 25–37.
138. [138] Graf, B.L., Raskin, I., Cefalu, W.T., Ribnicky, D.M., Plant-derived therapeutics for the treatment of metabolic syndrome. Curr. Opin. Investig. Drugs 11 (2010), 1107–1115.
139. [139] Jadeja, R.N., Thounaojam, M.C., Ansarullah Patel, V.B., Devkar, R.V., Ramachandran, A.V., Protective effect of Clerodendron glandulosum extract against experimentally induced metabolic syndrome in rats. Pharm. Biol. 48 (2010), 1312–1319.
140. [140] Meskheli, M.B., Antelava, N.A., Bakuridze, A.D., Berishvili, E.R., Pachkoriia, K.Z., Antidiabetic activity of berberin and extract, obtained from the bark of phellodendron lavalei, introduced in subtropic regions of georgia, in streptozotocin induced diabetic rats. Georgian Med. News, 2011, 53–60.
141. [141] Montefusco-Pereira, C.V., de Carvalho, M.J., de Araujo Boleti, A.P., Teixeira, L.S., Matos, H.R., Lima, E.S., Antioxidant, anti-inflammatory, and hypoglycemic effects of the leaf extract from Passiflora nitida kunth. Appl. Biochem. Biotechnol. 170 (2013), 1367–1378.
142. [142] Al-Rasheed, N., Al-Rasheed, N., Bassiouni, Y., Faddah, L., Mohamad, A.M., Potential protective effects of Nigella sativa and Allium sativum against fructose-induced metabolic syndrome in rats. J. Oleo Sci. 63 (2014), 839–848.
143. [143] Hosseini, A., Hosseinzadeh, H., A review on the effects of Allium sativum (garlic) in metabolic syndrome. J. Endocrinol. Investig. 38 (2015), 1147–1157.
144. [144] Sertie, J.A., Basile, A.C., Panizza, S., Matida, A.K., Zelnik, R., Anti-inflammatory activity and sub-acute toxicity of artemetin. Planta Med. 56 (1990), 36–40.
145. [145] Sertie, J.A., Basile, A.C., Panizza, S., Matida, A.K., Zelnik, R., Pharmacological assay of Cordia verbenacea; part 1. Anti-inflammatory activity and toxicity of the crude extract of the leaves. Planta Med. 54 (1988), 7–10.
146. [146] Sertie, J.A., Basile, A.C., Panizza, S., Oshiro, T.T., Azzolini, C.P., Penna, S.C., Pharmacological assay of Cordia verbenacea. Iii: oral and topical antiinflammatory activity and gastrotoxicity of a crude leaf extract. J. Ethnopharmacol. 31 (1991), 239–247.
147. [147] Sertie, J.A., Woisky, R.G., Wiezel, G., Rodrigues, M., Pharmacological assay of Cordia verbenacea v: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. Phytomedicine 12 (2005), 338–344.
148. [148] Passos, G.F., Fernandes, E.S., da Cunha, F.M., Ferreira, J., Pianowski, L.F., Campos, M.M., Calixto, J.B., Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from Cordia verbenacea. J. Ethnopharmacol. 110 (2007), 323–333.
149. [149] Medeiros, R., Passos, G.F., Vitor, C.E., Koepp, J., Mazzuco, T.L., Pianowski, L.F., Campos, M.M., Calixto, J.B., Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by lps in the rat paw. Br. J. Pharmacol. 151 (2007), 618–627.
150. [150] Fernandes, E.S., Passos, G.F., Medeiros, R., da Cunha, F.M., Ferreira, J., Campos, M.M., Pianowski, L.F., Calixto, J.B., Anti-inflammatory effects of compounds alpha-humulene and (–)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur. J. Pharmacol. 569 (2007), 228–236.
151. [151] Rogerio, A.P., Andrade, E.L., Leite, D.F., Figueiredo, C.P., Calixto, J.B., Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation. Br. J. Pharmacol. 158 (2009), 1074–1087.
152. [152] Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.Z., Xie, X.Q., Altmann, K.H., Karsak, M., Zimmer, A., Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 9099–9104.
153. [153] Bahi, A., Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S.M., Ojha, S., Beta-caryophyllene, a cb2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol. Behav. 135 (2014), 119–124.
154. [154] Cheng, Y., Dong, Z., Liu, S., Beta-caryophyllene ameliorates the alzheimer-like phenotype in app/ps1 mice through cb2 receptor activation and the ppargamma pathway. Pharmacology 94 (2014), 1–12.
155. [155] Chaves, J.S., Leal, P.C., Pianowisky, L., Calixto, J.B., Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice. Planta Med. 74 (2008), 1678–1683.
156. [156] Ticli, F.K., Hage, L.I., Cambraia, R.S., Pereira, P.S., Magro, A.J., Fontes, M.R., Stabeli, R.G., Giglio, J.R., Franca, S.C., Soares, A.M., Sampaio, S.V., Rosmarinic acid, a new snake venom phospholipase a2 inhibitor from Cordia verbenacea (boraginaceae): antiserum action potentiation and molecular interaction. Toxicon 46 (2005), 318–327.
157. [157] de Oliveira, D.M., Luchini, A.C., Seito, L.N., Gomes, J.C., Crespo-Lopez, M.E., Di Stasi, L.C., Cordia verbenacea and secretion of mast cells in different animal species. J. Ethnopharmacol. 135 (2011), 463–468.
158. [158] Pimentel, S.P., Barrella, G.E., Casarin, R.C., Cirano, F.R., Casati, M.Z., Foglio, M.A., Figueira, G.M., Ribeiro, F.V., Protective effect of topical Cordia verbenacea in a rat periodontitis model: immune-inflammatory, antibacterial and morphometric assays. BMC Complement. Altern. Med., 12, 2012, 224.
159. [159] Perini, J.A., Angeli-Gamba, T., Alessandra-Perini, J., Ferreira, L.C., Nasciutti, L.E., Machado, D.E., Topical application of acheflan on rat skin injury accelerates wound healing: a histopathological, immunohistochemical and biochemical study. BMC Complement. Altern. Med., 15, 2015, 203.
160. [160] Betancur-Galvis, L.A., Morales, G.E., Forero, J.E., Roldan, J., Cytotoxic and antiviral activities of colombian medicinal plant extracts of the Euphorbia genus. Memorias Instituto Oswaldo Cruz 97 (2002), 541–546.
161. [161] MacNeil, A., Sumba, O.P., Lutzke, M.L., Moormann, A., Rochford, R., Activation of the epstein-barr virus lytic cycle by the latex of the plant Euphorbia tirucalli. Br. J. Cancer 88 (2003), 1566–1569.
162. [162] Silva, A.C., de Faria, D.E., Borges, N.B., de Souza, I.A., Peters, V.M., Guerra Mde, O., Toxicological screening of Euphorbia tirucalli l.: developmental toxicity studies in rats. J. Ethnopharmacol. 110 (2007), 154–159.
163. [163] Valadares, M.C., Carrucha, S.G., Accorsi, W., Queiroz, M.L., Euphorbia tirucalli l. modulates myelopoiesis and enhances the resistance of tumour-bearing mice. Int. Immunopharmacol. 6 (2006), 294–299.
164. [164] Bani, S., Kaul, A., Khan, B., Gupta, V.K., Satti, N.K., Suri, K.A., Qazi, G.N., Anti-arthritic activity of a biopolymeric fraction from Euphorbia tirucalli. J. Ethnopharmacol. 110 (2007), 92–98.
165. [165] Dutra, R.C., de Souza, P.R., Bento, A.F., Marcon, R., Bicca, M.A., Pianowski, L.F., Calixto, J.B., Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms. Biochem. Pharmacol. 83 (2012), 531–542.
166. [166] Passos, G.F., Medeiros, R., Marcon, R., Nascimento, A.F., Calixto, J.B., Pianowski, L.F., The role of pkc/erk1/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on tpa-induced skin inflammation in mice. Eur. J. Pharmacol. 698 (2013), 413–420.
167. [167] Abreu, C.M., Price, S.L., Shirk, E.N., Cunha, R.D., Pianowski, L.F., Clements, J.E., Tanuri, A., Gama, L., Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral ltr. PLoS One, 9, 2014, e97257.
168. [168] Dutra, R.C., Simao da Silva, K.A., Bento, A.F., Marcon, R., Paszcuk, A.F., Meotti, F.C., Pianowski, L.F., Calixto, J.B., Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system. Neuropharmacology 63 (2012), 593–605.
169. [169] Dutra, R.C., Bicca, M.A., Segat, G.C., Silva, K.A., Motta, E.M., Pianowski, L.F., Costa, R., Calixto, J.B., The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: the potential role of pkcepsilon. Neuroscience 303 (2015), 126–137.
170. [170] King, A.R., Dotsey, E.Y., Lodola, A., Jung, K.M., Ghomian, A., Qiu, Y., Fu, J., Mor, M., Piomelli, D., Discovery of potent and reversible monoacylglycerol lipase inhibitors. Chem. Biol. 16 (2009), 1045–1052.
171. [171] Lin, M.W., Lin, A.S., Wu, D.C., Wang, S.S., Chang, F.R., Wu, Y.C., Huang, Y.B., Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of erk1/2-mediated apoptosis. Food Chem. Toxicol. 50 (2012), 4333–4339.
172. [172] Wang, L., Wang, G., Yang, D., Guo, X., Xu, Y., Feng, B., Kang, J., Euphol arrests breast cancer cells at the g1 phase through the modulation of cyclin d1, p21 and p27 expression. Mol. Med. Rep. 8 (2013), 1279–1285.
173. [173] Lebwohl, M., Swanson, N., Anderson, L.L., Melgaard, A., Xu, Z., Berman, B., Ingenol mebutate gel for actinic keratosis. N. Engl. J. Med. 366 (2012), 1010–1019.
174. [174] Tzogani, K., Nagercoil, N., Hemmings, R.J., Samir, B., Gardette, J., Demolis, P., Salmonson, T., Pignatti, F., The european medicines agency approval of ingenol mebutate (picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the committee for medicinal products for human use (chmp). Eur. J. Dermatol. 24 (2014), 457–463.
175. [175] Keating, G.M., Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis. Drugs 72 (2012), 2397–2405.
176. [176] Araujo Sde, S., Fernandes, T.C., Cardona, Y.T., Almeida, P.M., Marin-Morales, M.A., Dos Santos, A.V., Randau, K.P., Benko-Iseppon, A.M., Brasileiro-Vidal, A.C., Cytotoxic and genotoxic effects of ethanolic extract of Euphorbia hyssopifolia l. on hepg2 cells. J. Ethnopharmacol. 170 (2015), 16–19.
177. [177] Mello-Silva, C.C., de Vasconcellos, M.C., Bezerra, J.C., Rodrigues Mde, L., Pinheiro, J., The influence of exposure to Euphorbia splendens var. hislopii latex on the concentrations of total proteins and nitrogen products in biomphalaria glabrata infected with schistosoma mansoni. Acta Trop. 117 (2011), 101–104.
178. [178] Dias-Baruffi, M., Sakamoto, M., Rossetto, S., Vozari-Hampe, M.M., Roque-Barreira, M.C., Neutrophil migration and aggregation induced by euphorbin, a lectin from the latex of Euphorbia milii, var. milii. Inflamm. Res. 49 (2000), 732–736.
179. [179] Delgado, I.F., De-Carvalho, R.R., De-Oliveira, A.C., Kuriyama, S.N., Oliveira-Filho, E.C., Souza, C.A., Paumgartten, F.J., Absence of tumor promoting activity of Euphorbia milii latex on the mouse back skin. Toxicol. Lett. 145 (2003), 175–180.
180. [180] Fonseca, K.C., Morais, N.C., Queiroz, M.R., Silva, M.C., Gomes, M.S., Costa, J.O., Mamede, C.C., Torres, F.S., Penha-Silva, N., Beletti, M.E., Canabrava, H.A., Oliveira, F., Purification and biochemical characterization of eumiliin from Euphorbia milii var. hislopii latex. Phytochemistry 71 (2010), 708–715.
181. [181] Garbe, C., Basset-Seguin, N., Poulin, Y., Larsson, T., Osterdal, M.L., Venkata, R., Lear, J.T., Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0.015% gel: a randomised controlled 12-month study. Br. J. Dermatol., 2015.
182. [182] Calixto, J.B., Yunes, R.A., Natural bradykinin antagonists. Memorias Instituto Oswaldo Cruz 86:Suppl. 2 (1991), 195–202.
183. [183] Calixto, J.B., Yunes, R.A., Antagonism of kinin-induced contraction of isolated rat uterus by the crude hydroalcoholic extract from mandevilla illustris. Gen. Pharmacol. 22 (1991), 99–101.
184. [184] Momma, K., Toyoshima, K., Sun, F., Nakanishi, T., In vivo dilatation of the ductus arteriosus by rho kinase inhibition in the rat. Neonatology 95 (2009), 324–331.
185. [185] Neves, P.C., Neves, M.C., Cruz, A.B., Sant'Ana, A.E., Yunes, R.A., Calixto, J.B., Differential effects of Mandevilla velutina compounds on paw oedema induced by phospholipase a2 and phospholipase c. Eur. J. Pharmacol. 243 (1993), 213–219.
186. [186] Biondo, R., Pereira, A.M., Marcussi, S., Pereira, P.S., Franca, S.C., Soares, A.M., Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (apocynaceae) aqueous extract. Biochimie 85 (2003), 1017–1025.
187. [187] Henriques, M.G., Fernandes, P.D., Weg, V.B., Yunes, R.A., Cordeiro, R.S., Calixto, J.B., Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina. Agents Actions 33 (1991), 272–278.
188. [188] Calixto, J.B., Yunes, R.A., Cruz, A.B., Medeiros, Y.S., Effect of compounds from Mandevilla velutina on bradykinin-mediated contractile and relaxant responses of the isolated guinea pig trachea. Agents Actions 36 (1992), 222–229.
189. [189] Santos, A.A. Jr., Leal, P.C., Edelweiss, M.I., Lopes, T.G., Calixto, J.B., Morrone, F.B., Campos, M.M., Effects of the compounds mv8608 and mv8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 382 (2010), 399–407.
190. [190] Belichard, P., Luccarini, J.M., Defrene, E., Faye, P., Franck, R.M., Duclos, H., Paquet, J.L., Pruneau, D., Pharmacological and molecular evidence for kinin b1 receptor expression in urinary bladder of cyclophosphamide-treated rats. Br. J. Pharmacol. 128 (1999), 213–219.
191. [191] Mattos, W.M., Ferreira, J., Richetti, G.P., Niero, R., Yunes, R.A., Calixto, J.B., Antinociceptive properties produced by the pregnane compound velutinol a isolated from Mandevilla velutina. Neuropeptides 40 (2006), 125–132.
192. [192] Mattos, W.M., Campos, M.M., Fernandes, E.S., Richetti, G.P., Niero, R., Yunes, R.A., Calixto, J.B., Anti-edematogenic effects of velutinol a isolated from Mandevilla velutina: evidence for a selective inhibition of kinin b1 receptor-mediated responses. Regul. Pept. 136 (2006), 98–104.
193. [193] Calixto, J.B., Santos, A.R., Cechinel Filho, V., Yunes, R.A., A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential. Med. Res. Rev. 18 (1998), 225–258.
194. [194] Calixto, J.B., Yunes, R.A., Neto, A.S., Valle, R.M., Rae, G.A., Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: a comparative study with papaverine. Braz. J. Med. Biol. Res. 17 (1984), 313–321.
195. [195] Dias, M.A., Campos, A.H., Cechinel Filho, V., Yunes, R.A., Calixto, J.B., Analysis of the mechanisms underlying the contractile response induced by the hydroalcoholic extract of Phyllanthus urinaria in the guinea-pig urinary bladder in-vitro. J. Pharm. Pharmacol. 47 (1995), 846–851.
196. 2+ sensitive to ruthenium red. Gen. Pharmacol. 27 (1996), 795–802.
197. [197] Paulino, N., Cechinel-Filho, V., Yunes, R.A., Calixto, J.B., The relaxant effect of extract of Phyllanthus urinaria in the guinea-pig isolated trachea: evidence for involvement of atp-sensitive potassium channels. J. Pharm. Pharmacol. 48 (1996), 1158–1163.
198. [198] Chongsa, W., Kanokwiroon, K., Jansakul, C., Effects of 6 weeks oral administration of Phyllanthus acidus leaf water extract on the vascular functions of middle-aged male rats. J. Ethnopharmacol., 2015.
199. [199] Leeya, Y., Mulvany, M.J., Queiroz, E.F., Marston, A., Hostettmann, K., Jansakul, C., Hypotensive activity of an n-butanol extract and their purified compounds from leaves of Phyllanthus acidus (l.) skeels in rats. Eur. J. Pharmacol 649 (2010), 301–313.
200. [200] Lin, S.Y., Wang, C.C., Lu, Y.L., Wu, W.C., Hou, W.C., Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria. Food Chem. Toxicol. 46 (2008), 2485–2492.
201. [201] Fatima, N., Pingali, U., Pilli, R., Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects. Pharmacogn. Res. 6 (2014), 29–35.
202. [202] Santos, D.R., Chá de quebra-pedra (Phyllanthus niruri) na litíase urinaria em humanos e em ratos. Tese de Doutorado, 1990, Universidade Federal de São Paulo, Escola Paulista de Medicina p.159.
203. [203] Gorski, F., Correa, C.R., Filho, V.C., Yunes, R.A., Calixto, J.B., Potent antinociceptive activity of a hydroalcoholic extract of Phyllanthus corcovadensis. J. Pharm. Pharmacol. 45 (1993), 1046–1049.
204. [204] Chopade, A.R., Sayyad, F.J., Pain modulation by lignans (phyllanthin and hypophyllanthin) and tannin (corilagin) rich extracts of Phyllanthus amarus in carrageenan-induced thermal and mechanical chronic muscle hyperalgesia. Phytother. Res. 29 (2015), 1202–1210.
205. [205] Adedapo, A.A., Ofuegbe, S.O., Anti-inflammatory and antinociceptive activities of the aqueous leaf extract of Phyllanthus amarus schum (euphorbiaceae) in some laboratory animals. J. Basic Clin. Physiol. Pharmacol. 26 (2015), 89–94.
206. [206] Ofuegbe, S.O., Adedapo, A.A., Adeyemi, A.A., Anti-inflammatory and analgesic activities of the methanol leaf extract of Phyllanthus amarus in some laboratory animals. J. Basic Clin. Physiol. Pharmacol. 25 (2014), 175–180.
207. [207] Obidike, I.C., Salawu, O.A., Ndukuba, M., Okoli, C.O., Osunkwo, U.A., The anti-inflammatory and antinociceptive properties of the chloroform fraction from Phyllanthus niruri plant is mediated via the peripheral nervous system. J. Diet. Suppl. 7 (2010), 341–350.
208. [208] Kassuya, C.A., Silvestre, A., Menezes-de-Lima, O. Jr., Marotta, D.M., Rehder, V.L., Calixto, J.B., Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor. Eur. J. Pharmacol. 546 (2006), 182–188.
209. [209] Santos, A.R., De Campos, R.O., Miguel, O.G., Filho, V.C., Siani, A.C., Yunes, R.A., Calixto, J.B., Antinociceptive properties of extracts of new species of plants of the genus Phyllanthus (euphorbiaceae). J. Ethnopharmacol. 72 (2000), 229–238.
210. [210] Santos, A.R., De Campos, R.O., Miguel, O.G., Cechinel-Filho, V., Yunes, R.A., Calixto, J.B., The involvement of k+ channels and gi/o protein in the antinociceptive action of the gallic acid ethyl ester. Eur. J. Pharmacol. 379 (1999), 7–17.
211. [211] Cechinel Filho, V., Santos, A.R., De Campos, R.O., Miguel, O.G., Yunes, R.A., Ferrari, F., Messana, I., Calixto, J.B., Chemical and pharmacological studies of Phyllanthus caroliniensis in mice. J. Pharm. Pharmacol. 48 (1996), 1231–1236.
212. [212] Miguel, O.G., Calixto, J.B., Santos, A.R., Messana, I., Ferrari, F., Cechinel Filho, V., Pizzolatti, M.G., Yunes, R.A., Chemical and preliminary analgesic evaluation of geraniin and furosin isolated from Phyllanthus sellowianus. Planta Med. 62 (1996), 146–149.
213. [213] Santos, A.R., Niero, R., Filho, V.C., Yunes, R.A., Pizzolatti, M.G., Delle Monache, F., Calixto, J.B., Antinociceptive properties of steroids isolated from Phyllanthus corcovadensis in mice. Planta Med. 61 (1995), 329–332.
214. [214] Boeira, V.T., Leite, C.E., Santos, A.A. Jr., Edelweiss, M.I., Calixto, J.B., Campos, M.M., Morrone, F.B., Effects of the hydroalcoholic extract of Phyllanthus niruri and its isolated compounds on cyclophosphamide-induced hemorrhagic cystitis in mouse. Naunyn Schmiedeberg's Arch. Pharmacol. 384 (2011), 265–275.
215. [215] Molska, G.R., Negri, G., Paula-Freire, L.I., Araujo, L.P., Kohn, D.O., Basso, A.S., Carlini, E.A., Phyllanthus amarus does not affect hypernociception in experimental autoimmune encephalomyelitis. Planta Med. 80 (2014), 277–282.
216. [216] Jung, J., Kim, N.K., Park, S., Shin, H.J., Hwang, S.G., Kim, K., Inhibitory effect of Phyllanthus urinaria l. extract on the replication of lamivudine-resistant hepatitis b virus in vitro. BMC Complement. Altern. Med., 15, 2015, 255.
217. [217] Bawankule, D.U., Trivedi, P., Pal, A., Shanker, K., Singh, M., Sharma, P., Khan, F., Maurya, A.K., Verma, R.K., Gupta, M.M., Protective mechanism of lignans from Phyllanthus amarus against galactosamine/lipopolysaccharide-induced hepatitis: an in-vivo and in-silico studies. Curr. Top. Med. Chem. 14 (2014), 1045–1055.
218. [218] Bhattacharyya, S., Pal, P.B., Sil, P.C., A 35 kd Phyllanthus niruri protein modulates iron mediated oxidative impairment to hepatocytes via the inhibition of erks, p38 mapks and activation of pi3k/akt pathway. Food Chem. Toxicol. 56 (2013), 119–130.
219. [219] Lu, K.H., Yang, H.W., Su, C.W., Lue, K.H., Yang, S.F., Hsieh, Y.S., Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-pa via erk and akt signaling pathways. Food Chem. Toxicol. 52 (2013), 193–199.
220. [220] Fang, S.H., Rao, Y.K., Tzeng, Y.M., Anti-oxidant and inflammatory mediator's growth inhibitory effects of compounds isolated from Phyllanthus urinaria. J. Ethnopharmacol. 116 (2008), 333–340.
221. [221] Shen, B., Yu, J., Wang, S., Chu, E.S., Wong, V.W., Zhou, X., Lin, G., Sung, J.J., Chan, H.L., Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology 47 (2008), 473–483.
222. [222] Kiemer, A.K., Hartung, T., Huber, C., Vollmar, A.M., Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J. Hepatol. 38 (2003), 289–297.
223. [223] Dirjomuljono, M., Kristyono, I., Tjandrawinata, R.R., Nofiarny, D., Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int. J. Clin. Pharmacol. Ther. 46 (2008), 295–306.
224. [224] de Melo, M.N., Soares, L.A., Porto, C.R., de Araujo, A.A., Almeida, M., de Souza, T.P., Petrovick, P.R., de Araujo, R.F. Jr., Guerra, G.C., Spray-dried extract of Phyllanthus niruri l. reduces mucosal damage in rats with intestinal inflammation. J. Pharm. Pharmacol. 67 (2015), 1107–1118.
225. [225] Pradit, W., Chomdej, S., Nganvongpanit, K., Ongchai, S., Chondroprotective potential of Phyllanthus amarus schum. & thonn. in experimentally induced cartilage degradation in the explants culture model. In Vitro Cell. Dev. Biol. Anim. 51 (2015), 336–344.
226. [226] Sousa, M., Ousingsawat, J., Seitz, R., Puntheeranurak, S., Regalado, A., Schmidt, A., Grego, T., Jansakul, C., Amaral, M.D., Schreiber, R., Kunzelmann, K., An extract from the medicinal plant Phyllanthus acidus and its isolated compounds induce airway chloride secretion: a potential treatment for cystic fibrosis. Mol. Pharmacol. 71 (2007), 366–376.
227. [227] Gambari, R., Borgatti, M., Lampronti, I., Fabbri, E., Brognara, E., Bianchi, N., Piccagli, L., Yuen, M.C., Kan, C.W., Hau, D.K., Fong, W.F., Wong, W.Y., Wong, R.S., Chui, C.H., Corilagin is a potent inhibitor of nf-kappab activity and downregulates tnf-alpha induced expression of il-8 gene in cystic fibrosis ib3-1 cells. Int. Immunopharmacol. 13 (2012), 308–315.
228. [228] Liu, S., Wei, W., Li, Y., Lin, X., Shi, K., Cao, X., Zhou, M., In vitro and in vivo anti-hepatitis b virus activities of the lignan nirtetralin b isolated from Phyllanthus niruri l. J. Ethnopharmacol. 157 (2014), 62–68.
229. [229] Liu, S., Wei, W., Shi, K., Cao, X., Zhou, M., Liu, Z., In vitro and in vivo anti-hepatitis b virus activities of the lignan niranthin isolated from Phyllanthus niruri l. J. Ethnopharmacol. 155 (2014), 1061–1067.
230. [230] Amin, Z.A., Bilgen, M., Alshawsh, M.A., Ali, H.M., Hadi, A.H., Abdulla, M.A., Protective role of Phyllanthus niruri extract against thioacetamide-induced liver cirrhosis in rat model. Evid. Based Complement. Altern. Med., 2012, 2012, 241583.
231. [231] Krithika, R., Verma, R.J., Shrivastav, P.S., Suguna, L., Phyllanthin of standardized Phyllanthus amarus extract attenuates liver oxidative stress in mice and exerts cytoprotective activity on human hepatoma cell line. J. Clin. Exp. Hepatol. 1 (2011), 57–67.
232. [232] Pramyothin, P., Ngamtin, C., Poungshompoo, S., Chaichantipyuth, C., Hepatoprotective activity of Phyllanthus amarus Schum. Et. Thonn. extract in ethanol treated rats: in vitro and in vivo studies. J. Ethnopharmacol. 114 (2007), 169–173.
233. [233] Venkateswaran, P.S., Millman, I., Blumberg, B.S., Effects of an extract from Phyllanthus niruri on hepatitis b and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 274–278.
234. [234] Raphael, K.R., Kuttan, R., Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. J. Ethnopharmacol. 87 (2003), 193–197.
235. [235] Bandyopadhyay, S.K., Pakrashi, S.C., Pakrashi, A., The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J. Ethnopharmacol. 70 (2000), 171–176.
236. [236] Lai, C.H., Fang, S.H., Rao, Y.K., Geethangili, M., Tang, C.H., Lin, Y.J., Hung, C.H., Wang, W.C., Tzeng, Y.M., Inhibition of Helicobacter pylori-induced inflammation in human gastric epithelial ags cells by Phyllanthus urinaria extracts. J. Ethnopharmacol. 118 (2008), 522–526.
237. [237] Brusotti, G., Cesari, I., Gilardoni, G., Tosi, S., Grisoli, P., Picco, A.M., Caccialanza, G., Chemical composition and antimicrobial activity of Phyllanthus muellerianus (kuntze) excel essential oil. J. Ethnopharmacol. 142 (2012), 657–662.
238. [238] Brusotti, G., Cesari, I., Frassa, G., Grisoli, P., Dacarro, C., Caccialanza, G., Antimicrobial properties of stem bark extracts from Phyllanthus muellerianus (kuntze) excell. J. Ethnopharmacol. 135 (2011), 797–800.
239. [239] Oliveira, D.F., Pereira, A.C., Figueiredo, H.C., Carvalho, D.A., Silva, G., Nunes, A.S., Alves, D.S., Carvalho, H.W., Antibacterial activity of plant extracts from Brazilian southeast region. Fitoterapia 78 (2007), 142–145.
240. [240] Mensah, J.L., Lagarde, I., Ceschin, C., Michel, G., Gleye, J., Fouraste, I., Antibacterial activity of the leaves of Phyllanthus discoideus. J. Ethnopharmacol. 28 (1990), 129–133.
241. [241] Sharma, P., Parmar, J., Verma, P., Sharma, P., Goyal, P.K., Anti-tumor activity of Phyllanthus niruri (a medicinal plant) on chemical-induced skin carcinogenesis in mice. Asian Pac. J. Cancer Prev. 10 (2009), 1089–1094.
242. [242] Rajkapoor, B., Sankari, M., Sumithra, M., Anbu, J., Harikrishnan, N., Gobinath, M., Suba, V., Balaji, R., Antitumor and cytotoxic effects of Phyllanthus polyphyllus on ehrlich ascites carcinoma and human cancer cell lines. Biosci. Biotechnol. Biochem. 71 (2007), 2177–2183.
243. [243] Tuchinda, P., Kumkao, A., Pohmakotr, M., Sophasan, S., Santisuk, T., Reutrakul, V., Cytotoxic arylnaphthalide lignan glycosides from the aerial parts of Phyllanthus taxodiifolius. Planta Med. 72 (2006), 60–62.
244. [244] Tanaka, R., Kinouchi, Y., Wada, S., Tokuda, H., Potential anti-tumor promoting activity of lupane-type triterpenoids from the stem bark of Glochidion zeylanicum and Phyllanthus flexuosus. Planta Med. 70 (2004), 1234–1236.
245. [245] Huang, S.T., Yang, R.C., Yang, L.J., Lee, P.N., Pang, J.H., Phyllanthus urinaria triggers the apoptosis and bcl-2 down-regulation in lewis lung carcinoma cells. Life Sci. 72 (2003), 1705–1716.
246. [246] Rajeshkumar, N.V., Joy, K.L., Kuttan, G., Ramsewak, R.S., Nair, M.G., Kuttan, R., Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J. Ethnopharmacol. 81 (2002), 17–22.
247. [247] Rajeshkumar, N.V., Kuttan, R., Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J. Ethnopharmacol. 73 (2000), 215–219.
248. [248] Jeena, K.J., Joy, K.L., Kuttan, R., Effect of emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on n-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett. 136 (1999), 11–16.
249. [249] Blumberg, B.S., Millman, I., Venkateswaran, P.S., Thyagarajan, S.P., Hepatitis b virus and hepatocellular carcinoma—treatment of hbv carriers with Phyllanthus amarus. Cancer Detect. Prev. 14 (1989), 195–201.
250. [250] Tang, Y.Q., Jaganath, I.B., Manikam, R., Sekaran, S.D., Phyllanthus spp. exerts anti-angiogenic and anti-metastatic effects through inhibition on matrix metalloproteinase enzymes. Nutr. Cancer 67 (2015), 783–795.
251. [251] Tang, Y.Q., Jaganath, I.B., Manikam, R., Sekaran, S.D., Inhibition of mapks, myc/max, nfkappab, and hypoxia pathways by Phyllanthus prevents proliferation, metastasis and angiogenesis in human melanoma (mewo) cancer cell line. Int. J. Med. Sci. 11 (2014), 564–577.
252. [252] Jia, L., Jin, H., Zhou, J., Chen, L., Lu, Y., Ming, Y., Yu, Y., A potential anti-tumor herbal medicine, corilagin, inhibits ovarian cancer cell growth through blocking the tgf-beta signaling pathways. BMC Complement. Altern. Med., 13, 2013, 33.
253. [253] Ngamkitidechakul, C., Jaijoy, K., Hansakul, P., Soonthornchareonnon, N., Sireeratawong, S., Antitumour effects of phyllanthus emblica l.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother. Res. 24 (2010), 1405–1413.
254. [254] Obreza, A., Stegnar, M., Trampus-Bakija, A., Prezelj, A., Urleb, U., Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors. Pharmazie 59 (2004), 739–743.
255. [255] Chin, Y.W., Chai, H.B., Keller, W.J., Kinghorn, A.D., Lignans and other constituents of the fruits of Euterpe oleracea (acai) with antioxidant and cytoprotective activities. J. Agric. Food Chem. 56 (2008), 7759–7764.
256. [256] Schauss, A.G., Wu, X., Prior, R.L., Ou, B., Huang, D., Owens, J., Agarwal, A., Jensen, G.S., Hart, A.N., Shanbrom, E., Antioxidant capacity and other bioactivities of the freeze-dried amazonian palm berry, Euterpe oleraceae Mart. (Acai). J. Agric. Food Chem. 54 (2006), 8604–8610.
257. [257] Chen, Y.C., Chen, B.H., Determination of polycyclic aromatic hydrocarbons in fumes from fried chicken legs. J. Agric. Food Chem. 51 (2003), 4162–4167.
258. [258] Matheus, M.E., de Oliveira Fernandes, S.B., Silveira, C.S., Rodrigues, V.P., de Sousa Menezes, F., Fernandes, P.D., Inhibitory effects of Euterpe oleracea Mart. on nitric oxide production and inos expression. J. Ethnopharmacol. 107 (2006), 291–296.
259. [259] Rocha, A.P., Carvalho, L.C., Sousa, M.A., Madeira, S.V., Sousa, P.J., Tano, T., Schini-Kerth, V.B., Resende, A.C., Soares de Moura, R., Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (Acai) extracts in mesenteric vascular bed of the rat. Vasc. Pharmacol. 46 (2007), 97–104.
260. [260] Spada, P.D., Dani, C., Bortolini, G.V., Funchal, C., Henriques, J.A., Salvador, M., Frozen fruit pulp of Euterpe oleraceae Mart. (Acai) prevents hydrogen peroxide-induced damage in the cerebral cortex, cerebellum, and hippocampus of rats. J. Med. Food 12 (2009), 1084–1088.
261. [261] de Souza, M.O., Silva, M., Silva, M.E., Oliveira Rde, P., Pedrosa, M.L., Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition 26 (2010), 804–810.
262. [262] de Oliveira, P.R., da Costa, C.A., de Bem, G.F., de Cavalho, L.C., de Souza, M.A., de Lemos Neto, M., da Cunha Sousa, P.J., de Moura, R.S., Resende, A.C., Effects of an extract obtained from fruits of Euterpe oleracea mart. In the components of metabolic syndrome induced in c57bl/6j mice fed a high-fat diet. J. Cardiovasc. Pharmacol. 56 (2010), 619–626.
263. [263] Feio, C.A., Izar, M.C., Ihara, S.S., Kasmas, S.H., Martins, C.M., Feio, M.N., Maues, L.A., Borges, N.C., Moreno, R.A., Povoa, R.M., Fonseca, F.A., Euterpe oleracea (acai) modifies sterol metabolism and attenuates experimentally-induced atherosclerosis. J. Atheroscler. Thromb. 19 (2012), 237–245.
264. [264] de Souza, M.O., Souza, E.S.L., de Brito Magalhaes, C.L., de Figueiredo, B.B., Costa, D.C., Silva, M.E., Pedrosa, M.L., The hypocholesterolemic activity of acai (Euterpe oleracea mart.) is mediated by the enhanced expression of the atp-binding cassette, subfamily g transporters 5 and 8 and low-density lipoprotein receptor genes in the rat. Nutr. Res. 32 (2012), 976–984.
265. [265] Ribeiro, J.C., Antunes, L.M., Aissa, A.F., Darin, J.D., De Rosso, V.V., Mercadante, A.Z., Bianchi Mde, L., Evaluation of the genotoxic and antigenotoxic effects after acute and subacute treatments with Acai pulp (Euterpe oleracea Mart.) on mice using the erythrocytes micronucleus test and the comet assay. Mutat. Res. 695 (2010), 22–28.
266. [266] Moura, R.S., Ferreira, T.S., Lopes, A.A., Pires, K.M., Nesi, R.T., Resende, A.C., Souza, P.J., Silva, A.J., Borges, R.M., Porto, L.C., Valenca, S.S., Effects of Euterpe oleracea Mart. (Acai) extract in acute lung inflammation induced by cigarette smoke in the mouse. Phytomedicine 19 (2012), 262–269.
267. [267] de Moura, R.S., Pires, K.M., Santos Ferreira, T., Lopes, A.A., Nesi, R.T., Resende, A.C., Sousa, P.J., da Silva, A.J., Porto, L.C., Valenca, S.S., Addition of acai (Euterpe oleracea) to cigarettes has a protective effect against emphysema in mice. Food Chem. Toxicol. 49 (2011), 855–863.
268. [268] Fragoso, M.F., Prado, M.G., Barbosa, L., Rocha, N.S., Barbisan, L.F., Inhibition of mouse urinary bladder carcinogenesis by acai fruit (Euterpe oleraceae martius) intake. Plant Foods Hum. Nutr. 67 (2012), 235–241.
269. [269] da Silva Santos, V., Bisen-Hersh, E., Yu, Y., Cabral, I.S., Nardini, V., Culbreth, M., Teixeira da Rocha, J.B., Barbosa, F. Jr., Aschner, M., Anthocyanin-rich acai (Euterpe oleracea mart.) extract attenuates manganese-induced oxidative stress in rat primary astrocyte cultures. J. Toxicol. Environ. Health A 77 (2014), 390–404.
270. [270] Silva, D.F., Vidal, F.C., Santos, D., Costa, M.C., Morgado-Diaz, J.A., do Desterro Soares Brandao Nascimento, M., de Moura, R.S., Cytotoxic effects of Euterpe oleracea mart. In malignant cell lines. BMC Complement. Altern. Med., 14, 2014, 175.
271. [271] Zapata-Sudo, G., da Silva, J.S., Pereira, S.L., Souza, P.J., de Moura, R.S., Sudo, R.T., Oral treatment with Euterpe oleracea Mart. (acai) extract improves cardiac dysfunction and exercise intolerance in rats subjected to myocardial infarction. BMC Complement. Altern. Med., 14, 2014, 227.
272. [272] Sudo, R.T., Neto, M.L., Monteiro, C.E., Amaral, R.V., Resende, A.C., Souza, P.J., Zapata-Sudo, G., Moura, R.S., Antinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (acai) in a rodent model of acute and neuropathic pain. BMC Complement. Altern. Med., 15, 2015, 208.
273. [273] Souza-Monteiro, J.R., Hamoy, M., Santana-Coelho, D., Arrifano, G.P., Paraense, R.S., Costa-Malaquias, A., Mendonca, J.R., da Silva, R.F., Monteiro, W.S., Rogez, H., de Oliveira, D.L., do Nascimento, J.L., Crespo-Lopez, M.E., Anticonvulsant properties of Euterpe oleracea in mice. Neurochem. Int. 90 (2015), 20–27.
274. [274] Carvalho-Peixoto, J., Moura, M.R., Cunha, F.A., Lollo, P.C., Monteiro, W.D., Carvalho, L.M., Farinatti Pde, T., Consumption of acai (Euterpe oleracea mart.) functional beverage reduces muscle stress and improves effort tolerance in elite athletes: a randomized controlled intervention study. Appl. Physiol. Nutr. Metab. 40 (2015), 725–733.
275. [275] Toaldo, I.M., Cruz, F.A., Alves Tde, L., de Gois, J.S., Borges, D.L., Cunha, H.P., da Silva, E.L., Bordignon-Luiz, M.T., Bioactive potential of Vitis labrusca l. Grape juices from the southern region of Brazil: phenolic and elemental composition and effect on lipid peroxidation in healthy subjects. Food Chem. 173 (2015), 527–535.
276. [276] Lago-Vanzela, E.S., Da-Silva, R., Gomes, E., Garcia-Romero, E., Hermosin-Gutierrez, I., Phenolic composition of the edible parts (flesh and skin) of bordo grape (Vitis labrusca) using hplc-dad-esi-ms/ms. J. Agric. Food Chem. 59 (2011), 13136–13146.
277. [277] O'Byrne, D.J., Devaraj, S., Grundy, S.M., Jialal, I., Comparison of the antioxidant effects of concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am. J. Clin. Nutr. 76 (2002), 1367–1374.
278. [278] Soares De Moura, R., Costa Viana, F.S., Souza, M.A., Kovary, K., Guedes, D.C., Oliveira, E.P., Rubenich, L.M., Carvalho, L.C., Oliveira, R.M., Tano, T., Gusmao Correia, M.L., Antihypertensive, vasodilator and antioxidant effects of a vinifera grape skin extract. J. Pharm. Pharmacol. 54 (2002), 1515–1520.
279. [279] Madeira, S.V., de Castro Resende, A., Ognibene, D.T., de Sousa, M.A., Soares de Moura, R., Mechanism of the endothelium-dependent vasodilator effect of an alcohol-free extract obtained from a vinifera grape skin. Pharmacol. Res. 52 (2005), 321–327.
280. [280] Hort, M.A., Schuldt, E.Z., Bet, A.C., DalBo, S., Siqueira, J.M., Ianssen, C., Abatepaulo, F., de Souza, H.P., Veleirinho, B., Maraschin, M., Ribeiro-do-Valle, R.M., Anti-atherogenic effects of a phenol-rich fraction from Brazilian red wine (Vitis labrusca l.) in hypercholesterolemic low-density lipoprotein receptor knockout mice. J. Med. Food 15 (2012), 936–944.
281. [281] Dani, C., Oliboni, L.S., Agostini, F., Funchal, C., Serafini, L., Henriques, J.A., Salvador, M., Phenolic content of grapevine leaves (Vitis labrusca var. Bordo) and its neuroprotective effect against peroxide damage. Toxicol. In Vitro 24 (2010), 148–153.
282. [282] Andrade, E.R., Cruz, I.B., Andrade, V.V., Piccoli, J.C., Gonzalez-Gallego, J., Barrio, J.P., Gonzalez, P., Evaluation of the potential protective effects of ad libitum black grape juice against liver oxidative damage in whole-body acute x-irradiated rats. Food Chem. Toxicol. 49 (2011), 1026–1032.
283. [283] Aiub, C., Stankevicins, L., da Costa, V., Ferreira, F., Mazzei, J., Ribeiro da Silva, A., Soares de Moura, R., Felzenszwalb, I., Genotoxic evaluation of a vinifera skin extract that present pharmacological activities. Food Chem. Toxicol. 42 (2004), 969–973.
284. [284] Scola, G., Fernandes Correia Laurino, C.C., Menin, E., Salvador, M., Suppression of oncoprotein her-2 and DNA damage after treatment with flavan-3- ol Vitis labrusca extract. Anti Cancer Agents Med. Chem. 13 (2013), 1088–1095.
285. [285] Farahani, M.S., Bahramsoltani, R., Farzaei, M.H., Abdollahi, M., Rahimi, R., Plant-derived natural medicines for the management of depression: an overview of mechanisms of action. Rev. Neurosci. 26 (2015), 305–321.
286. [286] Viana, A.F., Heckler, A.P., Fenner, R., Rates, S.M., Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum (guttiferae). Braz. J. Med. Biol. Res. 36 (2003), 631–634.
287. [287] Haas, J.S., Viana, A.F., Heckler, A.P., von Poser, G.L., Rates, S.M., The antinociceptive effect of a benzopyran (hp1) isolated from Hypericum polyanthemum in mice hot-plate test is blocked by naloxone. Planta Med. 76 (2010), 1419–1423.
288. [288] Stolz, E.D., Viana, A.F., Hasse, D.R., von Poser, G.L., do Rego, J.C., Rates, S.M., Uliginosin b presents antinociceptive effect mediated by dopaminergic and opioid systems in mice. Prog. Neuro Psychopharmacol. Biol. Psychiatry 39 (2012), 80–87.
289. [289] Stolz, E.D., Hasse, D.R., von Poser, G.L., Rates, S.M., Uliginosin b, a natural phloroglucinol derivative, presents a multimediated antinociceptive effect in mice. J. Pharmacy Pharmacol. 66 (2014), 1774–1785.
290. [290] Daudt, R., von Poser, G.L., Neves, G., Rates, S.M., Screening for the antidepressant activity of some species of Hypericum from south Brazil. Phytother. Res. 14 (2000), 344–346.
291. [291] Viana, A.F., do Rego, J.C., Munari, L., Dourmap, N., Heckler, A.P., Costa, T.D., von Poser, G.L., Costentin, J., Rates, S.M., Hypericum caprifoliatum (guttiferae) cham. & schltdl.: a species native to south Brazil with antidepressant-like activity. Fundam. Clin. Pharmacol. 20 (2006), 507–514.
292. [292] Petroutsos, G., Paschides, C.A., Kitsos, G., Drosos, A.A., Psilas, K., Sterile corneal ulcers in dry eye Ii. Treatment, complications and course. J. Francais d'ophtalmologie 15 (1992), 106–111.
293. [293] Centuriao, F.B., Braga, A., Machado, F.R., Tagliari, B., Muller, L.G., Kolling, J., Poser, G., Wyse, A.T., Rates, S.M., Study of antidepressant-like activity of an enriched phloroglucinol fraction obtained from Hypericum caprifoliatum. Pharm. Biol. 52 (2014), 105–110.
294. [294] Haas, J.S., Stolz, E.D., Betti, A.H., Stein, A.C., Schripsema, J., Poser, G.L., Rates, S.M., The anti-immobility effect of hyperoside on the forced swimming test in rats is mediated by the d2-like receptors activation. Planta Med. 77 (2011), 334–339.
295. [295] Stein, A.C., Viana, A.F., Muller, L.G., Nunes, J.M., Stolz, E.D., Do Rego, J.C., Costentin, J., von Poser, G.L., Rates, S.M., Uliginosin b, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behav. Brain Res. 228 (2012), 66–73.
296. [296] Nobili, P., Crema, G., Ronchi, O., Percutaneous drainage of liver abscesses. Il Giornale di chirurgia 11 (1990), 365–370.
297. [297] Ferraz, A., Faria, D.H., Benneti, M.N., da Rocha, A.B., Schwartsmann, G., Henriques, A., von Poser, G.L., Screening for antiproliferative activity of six southern Brazilian species of Hypericum. Phytomedicine 12 (2005), 112–115.
298. [298] Grivicich, I., Ferraz, A., Faria, D.H., Regner, A., Schwartsmann, G., Henriques, A.T., von Poser, G.L., da Rocha, A.B., Synergistic effect of three benzopyrans isolated from Hypericum polyanthemum in u-373 mg glioblastoma cell line. Phytother. Res. 22 (2008), 1577–1580.
299. [299] Ferraz, A.B., Grivicich, I., von Poser, G.L., Faria, D.H., Kayser, G.B., Schwartsmann, G., Henriques, A.T., da Rocha, A.B., Antitumor activity of three benzopyrans isolated from Hypericum polyanthemum. Fitoterapia 76 (2005), 210–215.
300. [300] de Barros Falcao Ferraz, A., da Silva, J., Deimlimg, L.I., Santos-Mello, R., Sharlau, A., von Poser, G.L., Picada, J.N., Genotoxicity evaluation of three benzopyrans from Hypericum polyanthemum. Planta Med. 75 (2009), 37–40.
301. [301] Dagnino, A.P., Barros, F.M., Ccana-Ccapatinta, G.V., Prophiro, J.S., Poser, G.L., Romao, P.R., Leishmanicidal activity of lipophilic extracts of some Hypericum species. Phytomedicine 22 (2015), 71–76.
302. [302] Cargnin, S.T., Vieira Pde, B., Cibulski, S., Cassel, E., Vargas, R.M., Montanha, J., Roehe, P., Tasca, T., von Poser, G.L., Anti-Trichomonas vaginalis activity of Hypericum polyanthemum extract obtained by supercritical fluid extraction and isolated compounds. Parasitol. Int. 62 (2013), 112–117.
303. [303] Jorge, R.M., Leite, J.P., Oliveira, A.B., Tagliati, C.A., Evaluation of antinociceptive, anti-inflammatory and antiulcerogenic activities of Maytenus ilicifolia. J. Ethnopharmacol. 94 (2004), 93–100.
304. [304] Ohsaki, A., Imai, Y., Naruse, M., Ayabe, S., Komiyama, K., Takashima, J., Four new triterpenoids from Maytenus ilicifolia. J. Nat. Prod. 67 (2004), 469–471.
305. [305] Queiroga, C.L., Silva, G.F., Dias, P.C., Possenti, A., de Carvalho, J.E., Evaluation of the antiulcerogenic activity of friedelan-3beta-ol and friedelin isolated from Maytenus ilicifolia (celastraceae). J. Ethnopharmacol. 72 (2000), 465–468.
306. [306] Murakami, S., Muramatsu, M., Otomo, S., Gastric h+, k(+)-atpase inhibition by catechins. J. Pharm. Pharmacol. 44 (1992), 926–928.
307. [307] Ferreira, P.M., de Oliveira, C.N., de Oliveira, A.B., Lopes, M.J., Alzamora, F., Vieira, M.A., A lyophilized aqueous extract of Maytenus ilicifolia leaves inhibits histamine-mediated acid secretion in isolated frog gastric mucosa. Planta 219 (2004), 319–324.
308. [308] Baggio, C.H., Freitas, C.S., Twardowschy, A., dos Santosa, A.C., Mayer, B., Potrich, F.B., Cipriani, T.R., Sassaki, G.L., Iacomini, M., Marques, M.C., Mesia-Velaa, S., In vivo/in vitro studies of the effects of the type ii arabinogalactan isolated from Maytenus ilicifolia Mart. Ex. Reissek on the gastrointestinal tract of rats. Zeitschrift fur Naturforschung C. J. Biosci. 67 (2012), 405–410.
309. [309] Cipriani, T.R., Mellinger, C.G., de Souza, L.M., Baggio, C.H., Freitas, C.S., Marques, M.C., Gorin, P.A., Sassaki, G.L., Iacomini, M., A polysaccharide from a tea (infusion) of Maytenus ilicifolia leaves with anti-ulcer protective effects. J. Nat. Prod. 69 (2006), 1018–1021.
310. +-ATPase activity and formation of nitric oxide. J. Ethnopharmacol. 113 (2007), 433–440.
311. [311] da Silva, L.M., Boeing, T., Bordignon Somensi, L., Judah Cury, B., Bispo Steimbach, V.M., de Oliveira Silveria, A.C., Niero, R., Cechinel Filho, V., Roberto Santin, J., de Andrade, S.F., Evidence of gastric ulcer healing activity of maytenus robusta reissek: in vitro and in vivo studies. J. Ethnopharmacol., 2015.
312. [312] Haule, E.E., Moshi, M.J., Nondo, R.S., Mwangomo, D.T., Mahunnah, R.L., A study of antimicrobial activity, acute toxicity and cytoprotective effect of a polyherbal extract in a rat ethanol-HCL gastric ulcer model. BMC Res. Notes, 5, 2012, 546.
313. [313] de Andrade, S.F., Comunello, E., Noldin, V.F., Monache, F.D., Cechinel Filho, V., Niero, R., Antiulcerogenic activity of fractions and 3,15-dioxo-21alpha-hydroxy friedelane isolated from Maytenus robusta (celastraceae). Arch. Pharm. Res. 31 (2008), 41–46.
314. [314] Gonzalez, F.G., Portela, T.Y., Stipp, E.J., Di Stasi, L.C., Antiulcerogenic and analgesic effects of Maytenus aquifolium, Sorocea bomplandii and Zolernia ilicifolia. J. Ethnopharmacol. 77 (2001), 41–47.
315. [315] Bersani-Amado, C.A., Massao, L.B., Baggio, S.R., Johanson, L., Albiero, A.L., Kimura, E., Antiulcer effectiveness of Maytenus aquifolium spray dried extract. Phytother. Res. 14 (2000), 543–545.
316. [316] Baggio, C.H., Freitas, C.S., Mayer, B., Dos Santos, A.C., Twardowschy, A., Potrich, F.B., Cipriani, T.R., de Souza, L.M., Sassaki, G.L., Iacomini, M., Marques, M.C., Mesia-Vela, S., Muscarinic-dependent inhibition of gastric emptying and intestinal motility by fractions of Maytenus ilicifolia Mart. ex. Reissek. J. Ethnopharmacology 123 (2009), 385–391.
317. [317] Oliveira, M.G., Monteiro, M.G., Macaubas, C., Barbosa, V.P., Carlini, E.A., Pharmacologic and toxicologic effects of two maytenus species in laboratory animals. J. Ethnopharmacol. 34 (1991), 29–41.
318. [318] Vargas, V.M., Guidobono, R.R., Henriques, J.A., Genotoxicity of plant extracts. Memorias Instituto Oswaldo Cruz 86:Suppl. 2 (1991), 67–70.
319. [319] Montanari, T., de Carvalho, J.E., Dolder, H., Effect of Maytenus ilicifolia Mart. ex. Reiss on spermatogenesis. Contraception 57 (1998), 335–339.
320. [320] Montanari, T., Bevilacqua, E., Effect of Maytenus ilicifolia Mart. on pregnant mice. Contraception 65 (2002), 171–175.
321. [321] Cunha-Laura, A.L., Auharek, S.A., Oliveira, R.J., Siqueira, J.M., Vieira, M.C., Leite, V.S., Portugal, L.C., Effects of Maytenus ilicifolia on reproduction and embryo-fetal development in wistar rats. Genet. Mol. Res. 13 (2014), 3711–3720.
322. [322] Annuk, H., Hirmo, S., Turi, E., Mikelsaar, M., Arak, E., Wadstrom, T., Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts. FEMS Microbiol. Lett. 172 (1999), 41–45.
323. [323] Mabe, K., Yamada, M., Oguni, I., Takahashi, T., In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob. Agents Chemother. 43 (1999), 1788–1791.
324. [324] Singh, B., Dubey, M.M., Estimation of triterpenoids from Heliotropium marifolium Koen. ex. Retz. in vivo and in vitro. I. Antimicrobial screening. Phytother. Res. 15 (2001), 231–234.
325. [325] Portillo, A., Vila, R., Freixa, B., Adzet, T., Canigueral, S., Antifungal activity of paraguayan plants used in traditional medicine. J. Ethnopharmacol. 76 (2001), 93–98.
326. [326] Dos Santos, V.A., Leite, K.M., da Costa Siqueira, M., Regasini, L.O., Martinez, I., Nogueira, C.T., Galuppo, M.K., Stolf, B.S., Pereira, A.M., Cicarelli, R.M., Furlan, M., Graminha, M.A., Antiprotozoal activity of quinonemethide triterpenes from Maytenus ilicifolia (celastraceae). Molecules 18 (2013), 1053–1062.
327. [327] Zheng, G.Q., Cytotoxic terpenoids and flavonoids from artemisia annua. Planta Med. 60 (1994), 54–57.
328. [328] Okabe, S., Ochiai, Y., Aida, M., Park, K., Kim, S.J., Nomura, T., Suganuma, M., Fujiki, H., Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn. J. Cancer Res. 90 (1999), 733–739.
329. [329] Yamane, T., Takahashi, T., Kuwata, K., Oya, K., Inagake, M., Kitao, Y., Suganuma, M., Fujiki, H., Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (–)-epigallocatechin gallate in the rat glandular stomach. Cancer Res. 55 (1995), 2081–2084.
330. [330] Horn, R.C., Vargas, V.M., Antimutagenic activity of extracts of natural substances in the Salmonella/microsome assay. Mutagenesis 18 (2003), 113–118.
331. [331] Costa, P.M., Ferreira, P.M., Bolzani Vda, S., Furlan, M., de Freitas Formenton Macedo Dos Santos, V.A., Corsino, J., de Moraes, M.O., Costa-Lotufo, L.V., Montenegro, R.C., Pessoa, C., Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (celastraceae) in human hl-60 cells. Toxicol. In Vitro 22 (2008), 854–863.
332. [332] Araujo Junior, R.F., Oliveira, A.L., Pessoa, J.B., Garcia, V.B., Guerra, G.C., Soares, L.A., Souza, T.P., Petrovick, P.R., Araujo, A.A., Maytenus ilicifolia dry extract protects normal cells, induces apoptosis and regulates bcl-2 in human cancer cells. Exp. Biol. Med. 238 (2013), 1251–1258.
333. [333] Vellosa, J.C., Khalil, N.M., Formenton, V.A., Ximenes, V.F., Fonseca, L.M., Furlan, M., Brunetti, I.L., Oliveira, O.M., Antioxidant activity of Maytenus ilicifolia root bark. Fitoterapia 77 (2006), 243–244.
334. [334] Melo, S.F., Soares, S.F., da Costa, R.F., da Silva, C.R., de Oliveira, M.B., Bezerra, R.J., Caldeira-de-Araujo, A., Bernardo-Filho, M., Effect of the cymbopogon citratus, Maytenus ilicifolia and Baccharis genistelloides extracts against the stannous chloride oxidative damage in Escherichia coli. Mutat. Res. 496 (2001), 33–38.
335. [335] Ho, C.T., Chen, Q., Shi, H., Zhang, K.Q., Rosen, R.T., Antioxidative effect of polyphenol extract prepared from various chinese teas. Prev. Med. 21 (1992), 520–525.
336. [336] Krul, C., Luiten-Schuite, A., Tenfelde, A., van Ommen, B., Verhagen, H., Havenaar, R., Antimutagenic activity of green tea and black tea extracts studied in a dynamic in vitro gastrointestinal model. Mutat. Res. 474 (2001), 71–85.
337. [337] Dos Santos, V.A., Dos Santos, D.P., Castro-Gamboa, I., Zanoni, M.V., Furlan, M., Evaluation of antioxidant capacity and synergistic associations of quinonemethide triterpenes and phenolic substances from Maytenus ilicifolia (celastraceae). Molecules 15 (2010), 6956–6973.
338. [338] Rattmann, Y.D., Cipriani, T.R., Sassaki, G.L., Iacomini, M., Rieck, L., Marques, M.C., da Silva-Santos, J.E., Nitric oxide-dependent vasorelaxation induced by extractive solutions and fractions of Maytenus ilicifolia Mart. ex. Reissek (celastraceae) leaves. J. Ethnopharmacol. 104 (2006), 328–335.
339. [339] Crestani, S., Rattmann, Y.D., Cipriani, T.R., de Souza, L.M., Iacomini, M., Kassuya, C.A., Marques, M.C., da Silva-Santos, J.E., A potent and nitric oxide-dependent hypotensive effect induced in rats by semi-purified fractions from Maytenus ilicifolia. Vasc. Pharmacol. 51 (2009), 57–63.
340. [340] Leme Tdos, S., Prando, T.B., Gasparotto, F.M., de Souza, P., Crestani, S., de Souza, L.M., Cipriani, T.R., Lourenco, E.L., Gasparotto, A. Jr., Role of prostaglandin/camp pathway in the diuretic and hypotensive effects of purified fraction of Maytenus ilicifolia Mart. ex. Reissek (celastraceae). J. Ethnopharmacol. 150 (2013), 154–161.
341. [341] Fine, P.V., Daly, D.C., Villa Munoz, G., Mesones, I., Cameron, K.M., The contribution of edaphic heterogeneity to the evolution and diversity of burseraceae trees in the western Amazon. Evolution 59 (2005), 1464–1478.
342. [342] Oliveira, F.A., Costa, C.L., Chaves, M.H., Almeida, F.R., Cavalcante, I.J., Lima, A.F., Lima, R.C. Jr., Silva, R.M., Campos, A.R., Santos, F.A., Rao, V.S., Attenuation of capsaicin-induced acute and visceral nociceptive pain by alpha- and beta-amyrin, a triterpene mixture isolated from Protium heptaphyllum resin in mice. Life Sci. 77 (2005), 2942–2952.
343. [343] Otuki, M.F., Lima, F.V., Malheiros, A., Cechinel-Filho, V., Delle Monache, F., Yunes, R.A., Calixto, J.B., Evaluation of the antinociceptive action caused by ether fraction and a triterpene isolated from resin of Protium kleinii. Life Sci. 69 (2001), 2225–2236.
344. [344] Siani, A.C., Ramos, M.F., Menezes-de-Lima, O. Jr., Ribeiro-dos-Santos, R., Fernadez-Ferreira, E., Soares, R.O., Rosas, E.C., Susunaga, G.S., Guimaraes, A.C., Zoghbi, M.G., Henriques, M.G., Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. J. Ethnopharmacol. 66 (1999), 57–69.
345. [345] Duwiejua, M., Zeitlin, I.J., Waterman, P.G., Chapman, J., Mhango, G.J., Provan, G.J., Anti-inflammatory activity of resins from some species of the plant family burseraceae. Planta Med. 59 (1993), 12–16.
346. [346] Oliveira, F.A., Vieira-Junior, G.M., Chaves, M.H., Almeida, F.R., Florencio, M.G., Lima, R.C. Jr., Silva, R.M., Santos, F.A., Rao, V.S., Gastroprotective and anti-inflammatory effects of resin from Protium heptaphyllum in mice and rats. Pharmacol. Res. 49 (2004), 105–111.
347. [347] Medeiros, R., Otuki, M.F., Avellar, M.C., Calixto, J.B., Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-o-tetradecanoylphorbol-13-acetate. Eur. J. Pharmacol. 559 (2007), 227–235.
348. [348] Melo, C.M., Morais, T.C., Tome, A.R., Brito, G.A., Chaves, M.H., Rao, V.S., Santos, F.A., Anti-inflammatory effect of alpha, beta-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice. Inflamm. Res. 60 (2011), 673–681.
349. [349] Oliveira, F.A., Vieira-Junior, G.M., Chaves, M.H., Almeida, F.R., Santos, K.A., Martins, F.S., Silva, R.M., Santos, F.A., Rao, V.S., Gastroprotective effect of the mixture of alpha- and beta-amyrin from Protium heptaphyllum: role of capsaicin-sensitive primary afferent neurons. Planta Med. 70 (2004), 780–782.
350. [350] Matos, I., Bento, A.F., Marcon, R., Claudino, R.F., Calixto, J.B., Preventive and therapeutic oral administration of the pentacyclic triterpene alpha,beta-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system. Mol. Immunol. 54 (2013), 482–492.
351. [351] Oliveira, F.A., Chaves, M.H., Almeida, F.R., Lima, R.C. Jr., Silva, R.M., Maia, J.L., Brito, G.A., Santos, F.A., Rao, V.S., Protective effect of alpha- and beta-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice. J. Ethnopharmacol. 98 (2005), 103–108.
352. [352] Aragao, G.F., Cunha Pinheiro, M.C., Nogueira Bandeira, P., Gomes Lemos, T.L., de Barros Viana, G.S., Analgesic and anti-inflammatory activities of the isomeric mixture of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March. J. Herb. Pharmacother. 7 (2007), 31–47.
353. [353] Otuki, M.F., Ferreira, J., Lima, F.V., Meyre-Silva, C., Malheiros, A., Muller, L.A., Cani, G.S., Santos, A.R., Yunes, R.A., Calixto, J.B., Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase c and protein kinase a pathways. J. Pharmacol. Exp. Ther. 313 (2005), 310–318.
354. [354] Lima-Junior, R.C., Oliveira, F.A., Gurgel, L.A., Cavalcante, I.J., Santos, K.A., Campos, D.A., Vale, C.A., Silva, R.M., Chaves, M.H., Rao, V.S., Santos, F.A., Attenuation of visceral nociception by alpha- and beta-amyrin, a triterpenoid mixture isolated from the resin of Protium heptaphyllum, in mice. Planta Med. 72 (2006), 34–39.
355. [355] da Silva, K.A., Paszcuk, A.F., Passos, G.F., Silva, E.S., Bento, A.F., Meotti, F.C., Calixto, J.B., Activation of cannabinoid receptors by the pentacyclic triterpene alpha, beta-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain 152 (2011), 1872–1887.
356. [356] Chicca, A., Marazzi, J., Gertsch, J., The antinociceptive triterpene beta-amyrin inhibits 2-arachidonoylglycerol (2-ag) hydrolysis without directly targeting cannabinoid receptors. Br. J. Pharmacol. 167 (2012), 1596–1608.
357. [357] Santos, F.A., Frota, J.T., Arruda, B.R., de Melo, T.S., da Silva, A.A., Brito, G.A., Chaves, M.H., Rao, V.S., Antihyperglycemic and hypolipidemic effects of alpha, beta-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice. Lipids Health Dis., 11, 2012, 98.
358. [358] Carvalho, K.M., Marinho Filho, J.D., de Melo, T.S., Araujo, A.J., Quetz Jda, S., da Cunha Mdo, P., de Melo, K.M., da Silva, A.A., Tome, A.R., Havt, A., Fonseca, S.G., Brito, G.A., Chaves, M.H., Rao, V.S., Santos, F.A., The resin from Protium heptaphyllum prevents high-fat diet-induced obesity in mice: scientific evidence and potential mechanisms. Evid. Based Complement. Altern. Med., 2015, 2015, 106157.
359. [359] Mendes, F.R., Carlini, E.A., Brazilian plants as possible adaptogens: an ethnopharmacological survey of books edited in Brazil. J. Ethnopharmacol. 109 (2007), 493–500.
360. [360] Pizzolatti, M.G., Verdi, L.G., Brighente, I.M., Madureira, L.A., Braz Filho, R., Minor gamma-lactones from Trichilia catigua (meliaceae) and its precursors by GC–MS. Nat. Prod. Res. 18 (2004), 433–438.
361. [361] Pizzolatti, M.G., Venson, A.F., Smania, A. Jr., Smania Ede, F., Braz-Filho, R., Two epimeric flavalignans from Trichilia catigua (meliaceae) with antimicrobial activity Zeitschrift fur Naturforschung C. J. Biosci. 57 (2002), 483–488.
362. [362] Calixto, J.B., Cabrini, D.A., Herbal medicine catuama induces endothelium-dependent and -independent vasorelaxant action on isolated vessels from rats, guinea-pigs and rabbits. Phytother. Res., 1999, 11.
363. [363] Vaz, Z.R., Mata, L.V., Calixto, J.B., Analgesic effect of the herbal medicine catuama in thermal and chemical models of nociception in mice. Phytother. Res., 11, 1998, 5.
364. [364] Antunes, E., Gordo, W.M., de Oliveira, J.F., Teixeira, C.E., Hyslop, S., De Nucci, G., The relaxation of isolated rabbit corpus cavernosum by the herbal medicine catuama and its constituents. Phytother. Res. 15 (2001), 416–421.
365. [365] Oliveira, C.H., Moraes, M.E., Moraes, M.O., Bezerra, F.A., Abib, E., De Nucci, G., Clinical toxicology study of an herbal medicinal extract of Paullinia cupana, Trichilia catigua, Ptychopetalum olacoides and Zingiber officinale (catuama) in healthy volunteers. Phytother. Res. 19 (2005), 54–57.
366. [366] Campos, M.M., Fernandes, E.S., Ferreira, J., Bortolanza, L.B., Santos, A.R., Calixto, J.B., Pharmacological and neurochemical evidence for antidepressant-like effects of the herbal product Catuama. Pharmacol. Biochem. Behav. 78 (2004), 757–764.
367. [367] Pontieri, V., Neto, A.S., de Franca Camargo, A.F., Koike, M.K., Velasco, I.T., The herbal drug Catuama reverts and prevents ventricular fibrillation in the isolated rabbit heart. J. Electrocardiol. 40 (2007), 534 e531–538.
368. ® in inflammatory and neuropathic models of nociception in rats. Phytomedicine 15 (2008), 245–252.
369. [369] Spanemberg, J.C., Cherubini, K., de Figueiredo, M.A., Gomes, A.P., Campos, M.M., Salum, F.G., 2015 Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 113 (2012), 373–377.
370. [370] Barbosa, N.R., Fischmann, L., Talib, L.L., Gattaz, W.F., Inhibition of platelet phospholipase a2 activity by catuaba extract suggests antiinflammatory properties. Phytother. Res. 18 (2004), 942–944.
371. [371] Campos, M.M., Fernandes, E.S., Ferreira, J., Santos, A.R., Calixto, J.B., Antidepressant-like effects of Trichilia catigua (catuaba) extract: evidence for dopaminergic-mediated mechanisms. Psychopharmacology 182 (2005), 45–53.
372. [372] Chassot, J.M., Longhini, R., Gazarini, L., Mello, J.C., de Oliveira, R.M., Pre-clinical evaluation of Trichilia catigua extracts on the central nervous system of mice. J. Ethnopharmacol. 137 (2011), 1143–1148.
373. [373] Taciany Bonassoli, V., Micheli Chassot, J., Longhini, R., Milani, H., Mello, J.C., de Oliveira, R.M., Subchronic administration of Trichilia catigua ethyl-acetate fraction promotes antidepressant-like effects and increases hippocampal cell proliferation in mice. J. Ethnopharmacol. 143 (2012), 179–184.
374. [374] Viana, A.F., Maciel, I.S., Motta, E.M., Leal, P.C., Pianowski, L., Campos, M.M., Calixto, J.B., Antinociceptive activity of Trichilia catigua hydroalcoholic extract: new evidence on its dopaminergic effects. Evid. Based Complement. Altern. Med., 2011, 2011, 120820.
375. [375] Lonni, A.A., Munhoz, V.M., Lopes, G.C., Longhini, R., Borghi-Pangoni, F.B., Dos Santos, R.S., Junqueira, M.V., Natali, M.R., Leite-Mello, E., Guimaraes, F.B., Baesso, M.L., Scarminio, I.S., Bruschi, M.L., Mello, J.C., Development and characterization of multiple emulsions for controlled release of Trichilia catigua (catuaba) extract. Pharm. Dev. Technol., 2015, 1–10.
376. [376] Kamdem, J.P., Stefanello, S.T., Boligon, A.A., Wagner, C., Kade, I.J., Pereira, R.P., Preste Ade, S., Roos, D.H., Waczuk, E.P., Appel, A.S., Athayde, M.L., Souza, D.O., Rocha, J.B., In vitro antioxidant activity of stem bark of Trichilia catigua Adr. Juss. Acta Pharm. 62 (2012), 371–382.
377. [377] Truiti, M.T., Soares, L., Longhini, R., Milani, H., Nakamura, C.V., Mello, J.C., de Oliveira, R.M., Trichilia catigua ethyl-acetate fraction protects against cognitive impairments and hippocampal cell death induced by bilateral common carotid occlusion in mice. J. Ethnopharmacol. 172 (2015), 232–237.
378. [378] Dos Santos, A.H., Ramos, A.C., Silveira, K.M., Kiss, A.C., Longhini, R., Diniz, A., de Mello, J.C., Gerardin, D.C., The exposure to Trichilia catigua (catuaba) crude extract impairs fertility of adult female rats but does not cause reproductive damage to male offspring. J. Ethnopharmacol. 166 (2015), 86–91.
379. [379] Espada, S.F., Faccin-Galhardi, L.C., Rincao, V.P., Bernardi, A.L., Lopes, N., Longhini, R., de Mello, J.C., Linhares, R.E., Nozawa, C., Antiviral activity of Trichilia catigua bark extracts for herpesvirus and poliovirus. Curr. Pharm. Biotechnol. 16 (2015), 724–732.